<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39728964</article-id><article-id pub-id-type="pmc">PMC11680249</article-id>
<article-id pub-id-type="doi">10.3390/vetsci11120624</article-id><article-id pub-id-type="publisher-id">vetsci-11-00624</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Ehrlichia canis</italic> Vaccine Development: Challenges and Advances</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alves-Ribeiro</surname><given-names>Bruna Samara</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref><xref rid="af2-vetsci-11-00624" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Duarte</surname><given-names>Raiany Borges</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>de Assis-Silva</surname><given-names>Zara Mariana</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Ana Paula Carvalho</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Yasodaja Assis</given-names></name><xref rid="af2-vetsci-11-00624" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes-Silva</surname><given-names>Lizandra</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Rocha</surname><given-names>Alice Caroline da Silva</given-names></name><xref rid="af3-vetsci-11-00624" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Moraes</surname><given-names>Iago de S&#x000e1;</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8493-8669</contrib-id><name><surname>Saturnino</surname><given-names>Klaus Casaro</given-names></name><xref rid="af2-vetsci-11-00624" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9603-6638</contrib-id><name><surname>Ramos</surname><given-names>Dirceu Guilherme de Souza</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Taques</surname><given-names>Isis Indaiara Gon&#x000e7;alves Granjeiro</given-names></name><xref rid="af4-vetsci-11-00624" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Braga</surname><given-names>&#x000cd;sis Assis</given-names></name><xref rid="af1-vetsci-11-00624" ref-type="aff">1</xref><xref rid="c1-vetsci-11-00624" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kato</surname><given-names>Atsushi</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-11-00624"><label>1</label>Laboratory of Veterinary Parasitology and Clinical Analysis, Academic Unit of Agricultural Sciences, Federal University of Jata&#x000ed;, Jata&#x000ed; 75801-615, Goi&#x000e1;s, Brazil; <email>brunasamara@discente.ufj.edu.br</email> (B.S.A.-R.); <email>raiany.duarte@ufj.edu.br</email> (R.B.D.); <email>zaramariana@discente.ufj.edu.br</email> (Z.M.d.A.-S.); <email>anap_gomes@discente.ufj.edu.br</email> (A.P.C.G.); <email>lizandra_fernandes@discente.ufj.edu.br</email> (L.F.-S.); <email>iago.moraes@ufj.edu.br</email> (I.d.S.M.); <email>dguilherme@ufj.edu.br</email> (D.G.d.S.R.)</aff><aff id="af2-vetsci-11-00624"><label>2</label>Laboratory of Veterinary Anatomical Pathology, Academic Unit of Agricultural Sciences, Federal University of Jata&#x000ed;, Jata&#x000ed; 75801-615, Goi&#x000e1;s, Brazil; <email>yasodajaassis@ufj.edu.br</email> (Y.A.S.); <email>klaus.sat@ufj.edu.br</email> (K.C.S.)</aff><aff id="af3-vetsci-11-00624"><label>3</label>Academic Unit of Agricultural Sciences, Federal University of Jata&#x000ed;, Jata&#x000ed; 75801-615, Goi&#x000e1;s, Brazil; <email>alicerocha@discente.ufj.edu.br</email></aff><aff id="af4-vetsci-11-00624"><label>4</label>College of Applied Social Sciences of the S&#x000e3;o Louren&#x000e7;o Valley, EDUVALE, Cai&#x000e7;ara Street, 2.114, Jaciara 78820-000, Mato Grosso, Brazil; <email>isis@eduvalesl.edu.br</email></aff><author-notes><corresp id="c1-vetsci-11-00624"><label>*</label>Correspondence: <email>isisbraga@ufj.edu.br</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>11</volume><issue>12</issue><elocation-id>624</elocation-id><history><date date-type="received"><day>06</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>01</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>03</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Over the years, inactivated, live attenuated, and recombinant vaccines against <italic toggle="yes">Ehrlichia canis</italic> have been evaluated to mitigate the impact of canine monocytic ehrlichiosis. However, these results are not sufficient to produce an effective immunizing agent. New investigations can be conducted with the advancement of bioinformatics, immunoinformatics, and structural modeling tools, potentially ending a long-standing gap in research related to the development of vaccines against <italic toggle="yes">E. canis</italic>. Based on this technological advance, we are increasingly closer to developing a vaccine composed of multiple epitopes capable of eliciting robust humoral and cellular immune responses.</p></abstract><abstract><title>Abstract</title><p>Canine monocytic ehrlichiosis (CME) is an infectious disease caused by <italic toggle="yes">Ehrlichia canis</italic>, a globally recognized obligate intracellular bacterium. In addition to dogs, other animals, including humans, may be affected. Despite its epidemiological importance and impact on public health, there is currently no commercial vaccine against <italic toggle="yes">E. canis</italic>. This study aimed to present relevant aspects of the challenges and advances encountered in the development of vaccines for CME and highlight perspectives for future investigations. High genetic variability, along with the various evasion mechanisms employed by <italic toggle="yes">E. canis</italic>, has hindered the identification of an antigen that targets Th1 cells and is immunogenic to most <italic toggle="yes">E. canis</italic> isolates, considering their genotypic and phenotypic characteristics. The vaccine must predominantly confer cellular and humoral immunity to achieve robust immune responses. Early production efforts have been challenging due to low immunogenicity, difficulties in establishing long-term protection, and limitations of the techniques used. However, with the refinement of bioinformatic tools, research in this area will be facilitated, thereby accelerating the development of effective vaccines for CME. According to these authors, this vaccine should consist of multiple epitopes.</p></abstract><kwd-group><kwd>bioinformatics</kwd><kwd>canine monocytic ehrlichiosis</kwd><kwd>immunizing</kwd><kwd>immunoreactive proteins</kwd><kwd>tick-borne disease</kwd></kwd-group><funding-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior</funding-source></award-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Goi&#x000e1;s</funding-source><award-id>202310267001408</award-id></award-group><funding-statement>Scholarship provided to B.S.A.R.; Z.M.A.S..; Y.A.S.; L.F.S.; A.C.S.R. from Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior. Financial support provided by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de Goi&#x000e1;s, Protocol n&#x000b0; 202310267001408.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-11-00624"><title>1. Introduction</title><p>Canine monocytic ehrlichiosis (CME) is an infectious disease caused by <italic toggle="yes">Ehrlichia canis</italic>, an obligate intracellular bacterium transmitted by ticks. It mainly affects domestic dogs but can also infect other domestic and wild animals. There have also been reports of humans parasitized by <italic toggle="yes">E. canis</italic> [<xref rid="B1-vetsci-11-00624" ref-type="bibr">1</xref>,<xref rid="B2-vetsci-11-00624" ref-type="bibr">2</xref>,<xref rid="B3-vetsci-11-00624" ref-type="bibr">3</xref>,<xref rid="B4-vetsci-11-00624" ref-type="bibr">4</xref>].</p><p>Despite the significant epidemiological impact of <italic toggle="yes">E. canis</italic> on public health and the veterinary field, a vaccine against this pathogen is not commercially available. The absence of lipopolysaccharides (LPS) in this bacterium invalidates strategies against glycoconjugates. It requires the identification of protein antigens, which has been a major hurdle for researchers, given the mechanisms of immunological subversion and the high antigenic variability of the species [<xref rid="B5-vetsci-11-00624" ref-type="bibr">5</xref>,<xref rid="B6-vetsci-11-00624" ref-type="bibr">6</xref>].</p><p><italic toggle="yes">In vitro</italic> research and experimental needle inoculation, the latter a route used to infect dogs and murine models experimentally, are significant obstacles to vaccine development, as they do not reflect the reality of natural infection and, therefore, interfere with the practical assessment of the immune response [<xref rid="B7-vetsci-11-00624" ref-type="bibr">7</xref>]. However, after three decades of investigation, advances have been made in identifying the immunoreactive proteins of <italic toggle="yes">E. canis</italic>, such as p28, that acts as an outer membrane protein, the tandem repeat proteins (TRPs) TRP19, TRP36, TRP140, and ankyrin repeat protein (Ank200), some of which are targets for vaccine development [<xref rid="B8-vetsci-11-00624" ref-type="bibr">8</xref>].</p><p>Recent research has focused on developing immunogens for intracellular bacteria such as <italic toggle="yes">E. chaffeensis</italic>. Bioinformatics has streamlined the screening process, eliminating the need for <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> testing [<xref rid="B9-vetsci-11-00624" ref-type="bibr">9</xref>,<xref rid="B10-vetsci-11-00624" ref-type="bibr">10</xref>,<xref rid="B11-vetsci-11-00624" ref-type="bibr">11</xref>]. A team of researchers has successfully identified new hypothetical immunoreactive proteins in <italic toggle="yes">E. canis</italic> [<xref rid="B12-vetsci-11-00624" ref-type="bibr">12</xref>,<xref rid="B13-vetsci-11-00624" ref-type="bibr">13</xref>,<xref rid="B14-vetsci-11-00624" ref-type="bibr">14</xref>]. This discovery holds great promise for understanding the antigenic and immunogenic potential of these proteins.</p><p>The objective of this review is to present relevant aspects regarding the challenges and advances faced in the development of vaccines for <italic toggle="yes">E. canis</italic> and highlight perspectives for future investigations.</p></sec><sec id="sec2-vetsci-11-00624"><title>2. Canine Monocytic Ehrlichiosis</title><p>CME is an infectious disease caused by the obligate intracellular Gram-negative bacterium <italic toggle="yes">E. canis</italic> [<xref rid="B2-vetsci-11-00624" ref-type="bibr">2</xref>,<xref rid="B3-vetsci-11-00624" ref-type="bibr">3</xref>,<xref rid="B4-vetsci-11-00624" ref-type="bibr">4</xref>]. The ticks of the <italic toggle="yes">Rhipicephalus sanguineus</italic> complex represent the main vectors for transmission. Moreover, blood transfusion and vertical transmission are important routes of transmission [<xref rid="B15-vetsci-11-00624" ref-type="bibr">15</xref>,<xref rid="B16-vetsci-11-00624" ref-type="bibr">16</xref>]. The tick species have a heteroxenic cycle involving larval, nymph, and adult stages occurring in different hosts, making them susceptible to infection during blood feeding. However, only nymphs and adults can transmit the pathogen [<xref rid="B17-vetsci-11-00624" ref-type="bibr">17</xref>,<xref rid="B18-vetsci-11-00624" ref-type="bibr">18</xref>,<xref rid="B19-vetsci-11-00624" ref-type="bibr">19</xref>].</p><p>Despite its wide worldwide distribution, the prevalence of CME is higher in tropical and subtropical climate regions, where the <italic toggle="yes">R. sanguineus</italic> cycle is favored, especially during warmer periods of the year [<xref rid="B15-vetsci-11-00624" ref-type="bibr">15</xref>,<xref rid="B20-vetsci-11-00624" ref-type="bibr">20</xref>,<xref rid="B21-vetsci-11-00624" ref-type="bibr">21</xref>,<xref rid="B22-vetsci-11-00624" ref-type="bibr">22</xref>,<xref rid="B23-vetsci-11-00624" ref-type="bibr">23</xref>,<xref rid="B24-vetsci-11-00624" ref-type="bibr">24</xref>]. <italic toggle="yes">R. sanguineus</italic> has two well-defined lineages, temperate (<italic toggle="yes">R. sanguineus</italic> sensu stricto) and tropical (<italic toggle="yes">R. sanguineus</italic> sensu lato), distributed in the Americas and Western Europe and the Americas and South Africa, respectively [<xref rid="B25-vetsci-11-00624" ref-type="bibr">25</xref>,<xref rid="B26-vetsci-11-00624" ref-type="bibr">26</xref>,<xref rid="B27-vetsci-11-00624" ref-type="bibr">27</xref>,<xref rid="B28-vetsci-11-00624" ref-type="bibr">28</xref>]. Additionally, a new lineage was defined, showing genetic distinctness from <italic toggle="yes">R. sanguineus</italic> sensu lato between the Middle East and Eastern Europe regions [<xref rid="B29-vetsci-11-00624" ref-type="bibr">29</xref>].</p><p>Moraes-Filho et al. [<xref rid="B30-vetsci-11-00624" ref-type="bibr">30</xref>] and Sanches et al. [<xref rid="B31-vetsci-11-00624" ref-type="bibr">31</xref>] assign a greater vector competence to the tropical lineage compared to the temperate lineage. These studies provide essential data regarding the interaction of the <italic toggle="yes">R. sanguineus</italic> complex and <italic toggle="yes">E. canis</italic>. However, since new lineages are being discovered, further research will be necessary to determine the vector competence of these ticks. The tropical and temperate lineages of <italic toggle="yes">R. sanguineus</italic> are not only genetically distinct but also show differing proteomic reactions to infection. This fact supports the idea that they represent separate species with varying abilities to transmit <italic toggle="yes">E. canis</italic>. These findings aid in identifying potential targets for tick control and the prevention of tick-borne diseases, while also adding further insights into the ongoing discussion about the taxonomic classification of <italic toggle="yes">R. sanguineus</italic> [<xref rid="B31-vetsci-11-00624" ref-type="bibr">31</xref>].</p><p>After <italic toggle="yes">E. canis</italic> inoculation into susceptible dogs, the incubation period is 8 to 20 days, followed by acute, subclinical (asymptomatic), and chronic phases. The CME is a multisystemic disease and presents a series of challenges. As clinical and laboratory findings overlap with variable duration and severity, distinguishing each clinical phase in naturally infected dogs is a complex and challenging task. Hematologic abnormalities and clinical signs such as thrombocytopenia, anemia, depression, anorexia, weight loss, fever, and bleeding mark the acute phase. During the subclinical phase, dogs may either clear the infection spontaneously or remain infected while appearing clinically healthy for months to years. Eventually, some dogs may progress to a severe chronic infection characterized by hypoplastic bone marrow, bleeding, and death [<xref rid="B32-vetsci-11-00624" ref-type="bibr">32</xref>,<xref rid="B33-vetsci-11-00624" ref-type="bibr">33</xref>]. The development of clinical manifestations is related to several factors, such as the immunogenic and virulence characteristics of the strain involved in the infection, as well as the immune status of the host.</p><p>Genetic variability of <italic toggle="yes">E. canis</italic> has been reported in some isolates from different geographic regions after analysis of the 16S rRNA gene. Through analyses based on the tandem repeat protein 36 (TRP36) genes, it was possible to observe the variability of amino acid sequences among <italic toggle="yes">E. canis</italic> strains and generate genogroups. The genotypes include American (USTRP36), Brazilian (BrTRP36), Costa Rican (CRTRP36), Taiwanese, and Cuban (CUBTRP36), with different distributions on a global scale (<xref rid="vetsci-11-00624-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B3-vetsci-11-00624" ref-type="bibr">3</xref>,<xref rid="B8-vetsci-11-00624" ref-type="bibr">8</xref>,<xref rid="B34-vetsci-11-00624" ref-type="bibr">34</xref>,<xref rid="B35-vetsci-11-00624" ref-type="bibr">35</xref>,<xref rid="B36-vetsci-11-00624" ref-type="bibr">36</xref>,<xref rid="B37-vetsci-11-00624" ref-type="bibr">37</xref>,<xref rid="B38-vetsci-11-00624" ref-type="bibr">38</xref>,<xref rid="B39-vetsci-11-00624" ref-type="bibr">39</xref>,<xref rid="B40-vetsci-11-00624" ref-type="bibr">40</xref>,<xref rid="B41-vetsci-11-00624" ref-type="bibr">41</xref>,<xref rid="B42-vetsci-11-00624" ref-type="bibr">42</xref>]. Research reveals differences in the form of disease presentation in relation to the genotypes. Taques et al. [<xref rid="B43-vetsci-11-00624" ref-type="bibr">43</xref>], Borges et al. [<xref rid="B41-vetsci-11-00624" ref-type="bibr">41</xref>], and Zorzo et al. [<xref rid="B44-vetsci-11-00624" ref-type="bibr">44</xref>] have highlighted that the Brazilian genotype may be related to the chronic phase of CME because it is the most prevalent and adapted in Brazil. In contrast, the American genotype appears to be more pathogenic, causing more inflammatory signs. The Costa Rican genotype was less adapted to the immune response of animals from Brazil. Navarrete et al. [<xref rid="B37-vetsci-11-00624" ref-type="bibr">37</xref>] described dogs infected with the Cuban genotype as having more significant hemorrhagic tendencies, suggesting the possibility of the emergence of a more virulent strain.</p><p><italic toggle="yes">Ehrlichia</italic> infection in immunocompetent dogs has been associated with the development of a Th1 response with IFN-&#x003b3; secretion by CD4 T cells and changes in the CD4/CD8 ratio of T lymphocytes in peripheral blood, which may play pathogenic and protective roles [<xref rid="B19-vetsci-11-00624" ref-type="bibr">19</xref>]. Increases in the CD8+ cytotoxic T cell population have been detected in lymphoid organs and blood in experimental and natural cases of CME [<xref rid="B32-vetsci-11-00624" ref-type="bibr">32</xref>,<xref rid="B45-vetsci-11-00624" ref-type="bibr">45</xref>]. However, the dissemination of the bacteria may be facilitated by several evasion mechanisms that are initiated at the time of blood feeding by the vector, which contains components in its saliva that act as immunomodulators, reducing the production of IL-9, IL-2, and IL-4 in Th1 cells stimulated by IFN-&#x003b3; [<xref rid="B46-vetsci-11-00624" ref-type="bibr">46</xref>]</p><p>The absence of LPS in <italic toggle="yes">E. canis</italic> increases its survival in cellular vacuoles and its ability to inhibit phagolysosomal fusion in infected cells [<xref rid="B47-vetsci-11-00624" ref-type="bibr">47</xref>,<xref rid="B48-vetsci-11-00624" ref-type="bibr">48</xref>]. This inhibition results from the suppression of proteins that form complex juxtaposing vesicular membranes that hinder fusion and reduce IFN-&#x003b3; levels, which is inversely proportional to the frequency of <italic toggle="yes">Ehrlichia</italic>-infected cells [<xref rid="B49-vetsci-11-00624" ref-type="bibr">49</xref>].</p><p>Moreover, bacteria reduce the expression of the primary histocompatibility complex type I (MHC-I) and contribute to the maintenance of intracellular survival. During infection, there is a reduced expression of MHC-II, which is essential for the maturation of CD4+ T lymphocytes [<xref rid="B32-vetsci-11-00624" ref-type="bibr">32</xref>]. After 15 days of infection with <italic toggle="yes">E. canis</italic>, IgM immunoglobulins are detected in the bloodstream, marking the acute phase of the infection, while initial IgG levels are relatively low. As the infection progresses, predominantly comprising the IgG2 subclass, IgG titers increase notably, indicating the convalescent phase [<xref rid="B50-vetsci-11-00624" ref-type="bibr">50</xref>].</p><p>Tetracyclines continue to be the treatment of choice for ehrlichiosis in small animals, mainly doxycycline, but indiscriminate use has increased antimicrobial resistance [<xref rid="B51-vetsci-11-00624" ref-type="bibr">51</xref>]. Minocycline and oxytetracycline also act against these bacteria and are recommended when doxycycline is not available, refractory, or poorly tolerated [<xref rid="B52-vetsci-11-00624" ref-type="bibr">52</xref>]. Because of the many adverse effects of doxycycline treatment, alternatives for synergistic antimicrobial therapy of allopathic agents with natural plant actives are being studied [<xref rid="B53-vetsci-11-00624" ref-type="bibr">53</xref>]. Ros&#x000e1;rio et al. [<xref rid="B52-vetsci-11-00624" ref-type="bibr">52</xref>] showed that an aqueous fraction of <italic toggle="yes">Ageratum conyzoides</italic> associated with low doses of doxycycline has a promising, <italic toggle="yes">in vitro</italic>, anti-<italic toggle="yes">Ehrlichia</italic> action, being able to eliminate or suppress <italic toggle="yes">E. canis</italic>. Nonetheless, refractoriness and recrudescence of the bacteria have been reported after treatment [<xref rid="B54-vetsci-11-00624" ref-type="bibr">54</xref>,<xref rid="B55-vetsci-11-00624" ref-type="bibr">55</xref>].</p><p>Another challenging factor is ineffective tick control due to human failures and parasitic resistance mechanisms developed by vectors [<xref rid="B56-vetsci-11-00624" ref-type="bibr">56</xref>]. S&#x000e1;nchez-P&#x000e9;rez et al. [<xref rid="B57-vetsci-11-00624" ref-type="bibr">57</xref>] assumed, through mathematical models, a significant increase in <italic toggle="yes">R. sanguineus</italic> population in tropical and subtropical regions between 2050 and 2070 because of the climate changes currently being experienced, which will increase the suitable habitats for this tick&#x02019;s survival.</p></sec><sec id="sec3-vetsci-11-00624"><title>3. Challenges for Developing Vaccine for <italic toggle="yes">E. canis</italic></title><p>The challenges of formulating vaccines for CME are related to the complexity of the immunopathogenesis and the significant antigenic variability of <italic toggle="yes">E. canis</italic>, which make it difficult to select specific epitopes for effector cells. Since it is a tick-borne disease, the organic interactions required for the maintenance of the bacterium in the vector are also considered a challenge for disease control and the development of an effective vaccine. Differences in the microbiome of distinct <italic toggle="yes">R. sanguineus</italic> lineages have been described and suggest a direct relationship with the vector&#x02019;s competence [<xref rid="B58-vetsci-11-00624" ref-type="bibr">58</xref>]. In addition, the study of salivary proteins expressed by the tick during blood feeding has proven to be fundamental for the vector&#x02019;s development and effectiveness [<xref rid="B59-vetsci-11-00624" ref-type="bibr">59</xref>]. Additionally, the difficulty of maintaining <italic toggle="yes">E. canis</italic> culture, the use of <italic toggle="yes">in vitro</italic> techniques, and the routes and models used for experimental testing are limiting factors.</p><p>The host immune response effective to combat infection by bacteria of the <italic toggle="yes">Ehrlichia</italic> genus occurs through antigen presentation by conventional dendritic cells (CDC), followed by an acquired cellular immune response with activation of CD4+ cells in Th1 associated with humoral (Th2) responses [<xref rid="B32-vetsci-11-00624" ref-type="bibr">32</xref>,<xref rid="B49-vetsci-11-00624" ref-type="bibr">49</xref>]. The potential of vaccines targeting antigens for dendritic cells is a promising approach that may be effective against obligate intracellular bacteria. However, most research on the development of an immunogen for <italic toggle="yes">E. canis</italic> demonstrated the predominant triggering of humoral responses.</p><p>With the advancement of proteomics, several immunogenic proteins have been described and characterized as essential for the maintenance of infection. Outer membrane proteins (OMPs; P30/P28) [<xref rid="B60-vetsci-11-00624" ref-type="bibr">60</xref>], ankyrin repeat proteins (Anks) [<xref rid="B61-vetsci-11-00624" ref-type="bibr">61</xref>], and a group of proteins with amino acid repeat sequences (TRPs) have been identified in different species of <italic toggle="yes">Ehrlichia</italic> [<xref rid="B50-vetsci-11-00624" ref-type="bibr">50</xref>,<xref rid="B62-vetsci-11-00624" ref-type="bibr">62</xref>,<xref rid="B63-vetsci-11-00624" ref-type="bibr">63</xref>]. Luo et al. [<xref rid="B64-vetsci-11-00624" ref-type="bibr">64</xref>] reported that TRPs are involved in essential functions for the entry of <italic toggle="yes">Ehrlichia</italic> spp. into the host cell (phagocytosis, cytoskeletal reorganization, and intracellular transport) and replication mechanisms (cell signaling, metabolism, post-translational modification, and transcriptional regulation), in addition to interfering with the exit of <italic toggle="yes">Ehrlichia</italic> spp. in the infected cell (apoptosis and exocytosis). Bui et al. [<xref rid="B65-vetsci-11-00624" ref-type="bibr">65</xref>] reported that some TRPs are substrates of the type 1 secretion system (T1SS), which plays an important role in maintaining bacterial infection by secreting proteins that interact with a diverse network of targets in the host associated with essential cellular processes [<xref rid="B66-vetsci-11-00624" ref-type="bibr">66</xref>]. McBride et al. [<xref rid="B50-vetsci-11-00624" ref-type="bibr">50</xref>] highlight the importance of these proteins in immunodiagnosis and consider them essential targets for vaccine development [<xref rid="B67-vetsci-11-00624" ref-type="bibr">67</xref>].</p><p>Although TRP 19 is conserved among different isolates of <italic toggle="yes">E. canis</italic> and its ability to trigger antibody production has been verified, further studies need to be carried out on its potential to activate Th1 cells [<xref rid="B62-vetsci-11-00624" ref-type="bibr">62</xref>,<xref rid="B63-vetsci-11-00624" ref-type="bibr">63</xref>,<xref rid="B67-vetsci-11-00624" ref-type="bibr">67</xref>]. Similarly, another immunodominant protein, TRP36, has been studied for its immunogenic characteristics; however, because of the wide antigenic variation observed among <italic toggle="yes">E. canis</italic> isolates, its use as a vaccine antigen is limited. Aguiar et al. [<xref rid="B34-vetsci-11-00624" ref-type="bibr">34</xref>] described an <italic toggle="yes">E. canis</italic> isolate, #Cba16, that presented a unique combination of the American TR region and the N region of the Brazilian genotype. This finding suggests the possibility of genetic recombination owing to co-infection. It reinforces the hypothesis established by Doyle et al. [<xref rid="B67-vetsci-11-00624" ref-type="bibr">67</xref>], who stated that TRP36 is under a high level of selective pressure. Thus, it is believed that the effective immune response of a vaccine may be altered owing to differences in the pattern of the immune response in dogs exposed to different genotypes of <italic toggle="yes">E. canis</italic> and co-infection between them. In countries where there is a higher prevalence rate of CME and multiple reactivities, like Brazil, it is more challenging to develop an effective vaccine [<xref rid="B40-vetsci-11-00624" ref-type="bibr">40</xref>].</p><p>Another critical aspect to consider is the immune response produced by experimental needle inoculation, the route used to experimentally infect dogs and mice, compared to natural infection by tick transmission [<xref rid="B68-vetsci-11-00624" ref-type="bibr">68</xref>,<xref rid="B69-vetsci-11-00624" ref-type="bibr">69</xref>,<xref rid="B70-vetsci-11-00624" ref-type="bibr">70</xref>]. Patel et al. [<xref rid="B70-vetsci-11-00624" ref-type="bibr">70</xref>] reported that some immunoreactive proteins (TRPs) are highly expressed genes in mammalian cells. Nonetheless, most newly discovered proteins demonstrate higher expression levels in tick cells, suggesting they may be necessary for tick infection and transmission. The authors suggest that differences in host expression also illustrate how studies using only <italic toggle="yes">Ehrlichia</italic> produced in mammalian cells could be biased. However, they discuss the possibility of strongly immunoreactive proteins, highly expressed in ticks, likely to be important targets for transmission-blocking vaccines.</p></sec><sec id="sec4-vetsci-11-00624"><title>4. History of Vaccine Production for <italic toggle="yes">E. canis</italic></title><p>Research on <italic toggle="yes">E. canis</italic> began in 1970, with a focus on the characterization of its pathogenesis, clinical description, and immunological response after infection. This research is fundamental for the development of vaccines against ehrlichiosis [<xref rid="B71-vetsci-11-00624" ref-type="bibr">71</xref>,<xref rid="B72-vetsci-11-00624" ref-type="bibr">72</xref>,<xref rid="B73-vetsci-11-00624" ref-type="bibr">73</xref>,<xref rid="B74-vetsci-11-00624" ref-type="bibr">74</xref>,<xref rid="B75-vetsci-11-00624" ref-type="bibr">75</xref>]. Notably, Ristic and Holland [<xref rid="B75-vetsci-11-00624" ref-type="bibr">75</xref>] played a pivotal role as pioneers in the evaluation of an immunizer despite the limited publicity of their study.</p><p>In 1998, Breitschwerdt [<xref rid="B76-vetsci-11-00624" ref-type="bibr">76</xref>] conducted a study on 16 dogs experimentally infected with <italic toggle="yes">E. canis</italic> to verify the efficacy of doxycycline in the treatment of CME. In addition to the therapeutic results, they provide the first insights into the essential implications for the development of a vaccine after considering the roles of innate and adaptive immune responses. Mahan et al. [<xref rid="B77-vetsci-11-00624" ref-type="bibr">77</xref>] investigated the response of German Shepherds after immunization with an inactivated <italic toggle="yes">E. canis</italic> combined with the Quil A adjuvant. A bacteremia-suppressive effect was observed after the challenge. However, Western blot analysis revealed a short-lived response, with a drop in antibody titer, exposing the animals to reinfection.</p><p>Or et al. [<xref rid="B78-vetsci-11-00624" ref-type="bibr">78</xref>] inoculated two dogs intravenously with a suspension of attenuated <italic toggle="yes">E. canis</italic> (Israeli strain) through multiple passages in culture media. The analysis consisted of verifying the transmission to na&#x000ef;ve <italic toggle="yes">R. sanguineus</italic> and challenging the dogs after 119 days with a blood sample from a known infected dog. Nevertheless, the transmission of bacteria to ticks has not yet been verified. The immunized dogs developed bacteremia on day seven after the challenge, and one of them showed mild petechiae and splenomegaly. However, no hematological changes were observed in either dog. This study suggests the possibility of using <italic toggle="yes">E. canis</italic> attenuated by multiple passages in cell culture as a vaccine candidate. In another study using the same methodology, an additional study was conducted on 12 dogs, reinforcing the results described previously [<xref rid="B79-vetsci-11-00624" ref-type="bibr">79</xref>], but the immunity period was not evaluated in either study.</p><p>The use of primitive inactivated and live attenuated vaccines has led to undesirable effects and has not met expectations, and improvements in research using modern techniques have become evident. Advancements in reverse vaccinology have allowed for the identification of antigenic proteins, and the idealization of a peptide-based vaccine design has been employed [<xref rid="B7-vetsci-11-00624" ref-type="bibr">7</xref>,<xref rid="B8-vetsci-11-00624" ref-type="bibr">8</xref>,<xref rid="B80-vetsci-11-00624" ref-type="bibr">80</xref>,<xref rid="B81-vetsci-11-00624" ref-type="bibr">81</xref>]. In this context, research using murine models has been initiated to evaluate the dynamics of the immune response stimulated by synthetic peptides. The recombinant protein p29 from <italic toggle="yes">E. muris</italic> and the OMPs from <italic toggle="yes">E. chaffeensis</italic> p28 were the first targets of these investigations, and a significant reduction in bacterial load was observed, as well as the induction of a protective immune response in mice mediated by antibodies and T cells [<xref rid="B82-vetsci-11-00624" ref-type="bibr">82</xref>,<xref rid="B83-vetsci-11-00624" ref-type="bibr">83</xref>].</p><p>The identification of immunoreactive proteins of <italic toggle="yes">E. canis</italic>, followed by evidence of significant genetic and antigenic differences in antibody epitopes between the same <italic toggle="yes">E. canis</italic> strain [<xref rid="B8-vetsci-11-00624" ref-type="bibr">8</xref>,<xref rid="B63-vetsci-11-00624" ref-type="bibr">63</xref>], has stagnated the search for immunogens because of efforts to understand the immunopathogenic mechanisms of these synthesized proteins in natural infection. Moreover, the p19 protein of <italic toggle="yes">E. canis</italic> is the most conserved among these strains [<xref rid="B36-vetsci-11-00624" ref-type="bibr">36</xref>,<xref rid="B84-vetsci-11-00624" ref-type="bibr">84</xref>].</p><p>In a study, the <italic toggle="yes">in vitro</italic> neutralization capacity of hyperimmune serum synthesized from GP19 and produced in rabbits was evaluated, revealing promising data [<xref rid="B85-vetsci-11-00624" ref-type="bibr">85</xref>]. Subsequently, a prototype of a recombinant <italic toggle="yes">E. canis</italic> vaccine (rGP19) was tested in mice. The vaccinated group showed significantly higher mean antibody levels than the control group and a lower ehrlichial load in the blood. The authors suggested that immunogens effectively stimulate the immune response, enabling the organism to eliminate <italic toggle="yes">E. canis</italic> by stimulating CD4+ T cells, which produce IFN-&#x003b3;, in addition to the production of antibodies [<xref rid="B86-vetsci-11-00624" ref-type="bibr">86</xref>].</p><p>The preliminary production of a vaccine against <italic toggle="yes">E. canis</italic> is challenging because of its low immunogenicity, difficulty in long-term protection, genetic variability, and undesirable effects. Since the SARS-CoV-2 pandemic, researchers have developed new technologies that combine immunoinformatics and cell-free protein expression, directly leading to the resumption of targeted research for immunoreactive antigens in the development of vaccines against <italic toggle="yes">E. canis</italic> [<xref rid="B12-vetsci-11-00624" ref-type="bibr">12</xref>]. Luo et al. [<xref rid="B13-vetsci-11-00624" ref-type="bibr">13</xref>,<xref rid="B14-vetsci-11-00624" ref-type="bibr">14</xref>] identified 18 immunoreactive proteins of <italic toggle="yes">E. canis</italic> (TRP) using bioinformatics. They hypothesized that some proteins had conformational epitopes and were type I secreted effectors (T1SS), highlighting them as future candidates for vaccine antigens.</p><p>Recently, Patel et al., [<xref rid="B70-vetsci-11-00624" ref-type="bibr">70</xref>] evaluated seven of these newly discovered immunodominant proteins and found that, except for one, all reacted early, between 21 and 28 days post-infection, according to an enzyme-linked immunosorbent assay. Furthermore, it was found that some of these proteins were highly conserved among <italic toggle="yes">E. canis</italic> strains and that the peptide E.caj_0126 R2 reacted with sera from positive dogs from North and South America (USA, Colombia and Brazil), demonstrating conserved epitopes among the geographically dispersed <italic toggle="yes">E. canis</italic> strains.</p></sec><sec id="sec5-vetsci-11-00624"><title>5. Prospects for Vaccine Development Against <italic toggle="yes">E. canis</italic></title><p>After decades of research, we may be able to develop a vaccine against CME. Several studies have focused on identifying immunoreactive antigens of <italic toggle="yes">E. canis</italic> combined with reverse vaccinology and improving bioinformatics and structural modeling, which are essential for the development of vaccines against intracellular pathogens.</p><p>Bioinformatics is fundamental for identifying essential protein targets and non-host homologs in the pathogen proteome that can be used as potential vaccine candidate targets [<xref rid="B9-vetsci-11-00624" ref-type="bibr">9</xref>,<xref rid="B87-vetsci-11-00624" ref-type="bibr">87</xref>]. These proteins are generally involved in metabolic pathways critical for bacterial infectivity. Luo et al. [<xref rid="B12-vetsci-11-00624" ref-type="bibr">12</xref>,<xref rid="B14-vetsci-11-00624" ref-type="bibr">14</xref>] identified previously undiscovered hypothetical immunoreactive proteins in <italic toggle="yes">E. canis</italic> and provided additional options for immunogenic antigens. This discovery underscores the need for further studies to determine the T cell epitopes, secretion mechanisms, and functions of these proteins in <italic toggle="yes">Ehrlichia</italic> pathobiology and immunity. More recently, a linear antibody epitope termed E.caj_0126R2 has shown promise for future investigations, as it has been shown to be conserved among the different strains of <italic toggle="yes">E. canis</italic> distributed in the Americas [<xref rid="B70-vetsci-11-00624" ref-type="bibr">70</xref>].</p><p>The next crucial step is evaluation through immunoinformatics, focusing on targets that are immunodominant and effectors of the T1SS [<xref rid="B14-vetsci-11-00624" ref-type="bibr">14</xref>], as well as the proteins identified as TRP19, TRP36, TRP140, and Ank200 [<xref rid="B68-vetsci-11-00624" ref-type="bibr">68</xref>,<xref rid="B80-vetsci-11-00624" ref-type="bibr">80</xref>,<xref rid="B86-vetsci-11-00624" ref-type="bibr">86</xref>], to predict immune responses, particularly the interaction between epitopes and the host immune system, using tools that predict the antigenicity, allergenicity, and druggability of epitopes [<xref rid="B88-vetsci-11-00624" ref-type="bibr">88</xref>]. Research seeking to identify and evaluate pathogen epitopes unrelated to CME, transmitted by ticks, has also been conducted, with promising results [<xref rid="B9-vetsci-11-00624" ref-type="bibr">9</xref>,<xref rid="B11-vetsci-11-00624" ref-type="bibr">11</xref>].</p><p>Structural modeling is an essential component of computational vaccine design. Three-dimensional models of pathogenic proteins allow for the prediction of which protein conformations effectively trigger an immune response in a given host [<xref rid="B88-vetsci-11-00624" ref-type="bibr">88</xref>,<xref rid="B89-vetsci-11-00624" ref-type="bibr">89</xref>]. Computational tools, molecular docking simulations, and molecular dynamics are frequently employed to model the binding of epitopes to immune receptors and predict the stability and efficacy of potential vaccine candidates [<xref rid="B90-vetsci-11-00624" ref-type="bibr">90</xref>]. A multi-epitope vaccine against <italic toggle="yes">E. chaffeensis</italic> was designed, and immunological simulation analysis showed strong interactions with toll-like receptors and acceptable immunoreactivity, which this induced high levels of cytokine (IL-2 and IFN-&#x003b3;), B cells, and T cell populations [<xref rid="B11-vetsci-11-00624" ref-type="bibr">11</xref>].</p><p>Conformational or mixed antigenic epitopes can be identified through <italic toggle="yes">in silico</italic> experimental models. They can also be expressed by the MHC-II of cDC that activates Th1 and Th17 cell receptors. This activation is crucial as it leads to the intense stimulation of the CD4+ T cell immune response and, consequently, the secretion of IFN-&#x003b3;. Notably, CD4+ helper T cells play a pivotal role in driving the development of B cells, which differentiate into antibody-secreting plasma cells, memory cells, and long-lived plasma cells (LLPCs) that provide long-term and sustained antibody production. Epitopes for Th2 cell receptors are also desired, as a vaccine that produces a robust humoral, LLPC-stimulated, and T cell-mediated immune response will have a better chance of providing protection [<xref rid="B6-vetsci-11-00624" ref-type="bibr">6</xref>]. A strong cytotoxic cellular response to antigens is desirable. Although Th1 cells discretely stimulate the CD8 + T cell response, additional stimulation may be essential. The peptide presentation is required in a manner restricted to MHC-I, usually induced by antigen-presenting cells that secrete appropriate cytokines and co-stimulate cDCs to induce T cell differentiation [<xref rid="B91-vetsci-11-00624" ref-type="bibr">91</xref>] (<xref rid="vetsci-11-00624-f002" ref-type="fig">Figure 2</xref>). Therefore, subunit vaccines against <italic toggle="yes">E. canis</italic> would require new formulations of adjuvants specialized in cross-antigen presentation [<xref rid="B92-vetsci-11-00624" ref-type="bibr">92</xref>].</p><p>After identifying the epitopes and understanding the essential characteristics of a robust immune response against <italic toggle="yes">E. canis</italic>, the next step is to define the correlates of protection (CoPs) for licensing an effective vaccine. This phase depends on humoral responses, well-defined CoPs, and cell-mediated responses that are predominantly tissue-resident memory T cells (TRM), as predicted by Schaik et al. [<xref rid="B6-vetsci-11-00624" ref-type="bibr">6</xref>].</p><p>After the <italic toggle="yes">in silico</italic> approach, prototypes of vaccines structured with multiple <italic toggle="yes">E. canis</italic> epitopes should be tested <italic toggle="yes">in vivo</italic> in the preferred host or in experimental models that mimic natural infections as much as possible. Budachetri et al. [<xref rid="B93-vetsci-11-00624" ref-type="bibr">93</xref>,<xref rid="B94-vetsci-11-00624" ref-type="bibr">94</xref>] investigated the vaccine potential of proteins synthesized by <italic toggle="yes">E. chaffeensis</italic>. They found a high production of antibodies and IFN-&#x003b3; in immunized dogs, as well as rapid elimination of the bacteria. Vaccines against CME using immunoreactive proteins comprise two different delivery platforms: protein subunits and mRNA vaccines. The mRNA vaccines are more accessible and have a lower risk of adverse reactions [<xref rid="B95-vetsci-11-00624" ref-type="bibr">95</xref>].</p><p>Live attenuated vaccines (LAV) have been less explored in CME because of the difficulty in maintaining bacteria in cell culture. This methodology has been investigated using new attenuation approaches for the production of vaccines against another <italic toggle="yes">Ehrlichia</italic> species [<xref rid="B96-vetsci-11-00624" ref-type="bibr">96</xref>,<xref rid="B97-vetsci-11-00624" ref-type="bibr">97</xref>,<xref rid="B98-vetsci-11-00624" ref-type="bibr">98</xref>]. In one study, dogs were immunized with an attenuated mutant strain of <italic toggle="yes">E. chaffeensis,</italic> which produced antibodies and activated CD4+ T cells, consequently inducing protection for up to 12 months [<xref rid="B98-vetsci-11-00624" ref-type="bibr">98</xref>]. Similarly to LAV, DNA vaccines against <italic toggle="yes">E. canis</italic> have not been investigated. However, preliminary results indicate positive effects on the protection of <italic toggle="yes">E. ruminantium</italic> in animals [<xref rid="B99-vetsci-11-00624" ref-type="bibr">99</xref>,<xref rid="B100-vetsci-11-00624" ref-type="bibr">100</xref>].</p><p>Another prominent scenario involves strategies to control <italic toggle="yes">E. canis</italic> within the tick. Ferrolho and Dias have been working on studies highlighting potential targets, such as silencing ferritin and modulating the folate pathway to disrupt the pathogen&#x02019;s replication in the vector and impair its survival [<xref rid="B59-vetsci-11-00624" ref-type="bibr">59</xref>,<xref rid="B101-vetsci-11-00624" ref-type="bibr">101</xref>].</p></sec><sec sec-type="conclusions" id="sec6-vetsci-11-00624"><title>6. Conclusions</title><p>The new methodologies and machine-learning algorithms developed during the SARS-CoV-2 pandemic have stimulated curiosity among researchers, renewing expectations for the formulation of a vaccine against <italic toggle="yes">E. canis</italic>. In just a few years, we have accelerated the process of discovering potential antigens. The subsequent phases of the investigation are set to proceed rapidly and safely, aided by bioinformatics, immunoinformatics, structural modeling, and <italic toggle="yes">in vivo</italic> validation experiments.</p><p>The challenges remain, as <italic toggle="yes">E. canis</italic> is an intracellular bacterium with high genetic variability and poorly understood evasion mechanisms. However, we are close to developing a vaccine against CME. From the authors&#x02019; perspective, the vaccine should be structurally composed of multiple conformational and linear epitopes. In addition to activating B cells, these epitopes will have a strong binding affinity to CD4+ and CD8+ T cells, promoting the production of cytokines, such as IFN-&#x003b3;, that are essential for pathogen destruction. Additionally, control strategies aimed at disrupting the replication of <italic toggle="yes">E. canis</italic> in the vector would increase the chances of success in preventing CME.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank the Federal University of Jata&#x000ed; for the infrastructure provided, especially the Laboratory of Veterinary Parasitology and Clinical Analysis, and Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior for the scholarship to B.S.A.R.; Z.M.A.S.; Y.A.S.; L.F.S.; A.C.S.R.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>B.S.A.-R.; contextualization, drafting, editing, and formatting. R.B.D.; writing and revision. Z.M.d.A.-S.; drafting, editing, and formatting. A.P.C.G.; writing and translation. Y.A.S.; drafting and editing. L.F.-S.; writing and translation. A.C.d.S.R.; drafting. I.d.S.M.; drafting and translation. K.C.S.; writing, revision, and editing. D.G.d.S.R.; writing, revision, and editing. I.I.G.G.T.; writing, revision, supervision, and editing. &#x000cd;.A.B.; contextualization, writing, drafting, revision, supervision, editing, and guidance. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-11-00624"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dumler</surname><given-names>J.S.</given-names></name>
<name><surname>Barbet</surname><given-names>A.F.</given-names></name>
<name><surname>Bekker</surname><given-names>C.P.J.</given-names></name>
<name><surname>Dasch</surname><given-names>G.A.</given-names></name>
<name><surname>Palmer</surname><given-names>G.H.</given-names></name>
<name><surname>Ray</surname><given-names>S.C.</given-names></name>
<name><surname>Rikihisa</surname><given-names>Y.</given-names></name>
<name><surname>Rurangirwa</surname><given-names>F.R.</given-names></name>
</person-group><article-title>Reorganization of genera in the families <italic toggle="yes">Rickettsiaceae</italic> and <italic toggle="yes">Anaplasmataceae</italic> in the order Rickettsiales: Unification of some species of <italic toggle="yes">Ehrlichia</italic> with <italic toggle="yes">Anaplasma</italic>, Cowdria with <italic toggle="yes">Ehrlichia</italic> and <italic toggle="yes">Ehrlichia</italic> with <italic toggle="yes">Neorickettsia</italic>, descriptions of six new species combinations and designation of <italic toggle="yes">Ehrlichia equi</italic> and HGE agent as subjective synonyms of <italic toggle="yes">Ehrlichia phagocytophila</italic></article-title><source>Int. J. Syst. Evol. Microbiol.</source><year>2001</year><volume>51</volume><fpage>2145</fpage><lpage>2165</lpage><pub-id pub-id-type="doi">10.1099/00207713-51-6-2145</pub-id><pub-id pub-id-type="pmid">11760958</pub-id>
</element-citation></ref><ref id="B2-vetsci-11-00624"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Braga</surname><given-names>&#x000cd;.A.</given-names></name>
<name><surname>Santos</surname><given-names>L.G.F.D.</given-names></name>
<name><surname>Ramos</surname><given-names>D.G.D.S.</given-names></name>
<name><surname>Melo</surname><given-names>A.L.T.</given-names></name>
<name><surname>Mestre</surname><given-names>G.L.D.C.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Detection of <italic toggle="yes">Ehrlichia canis</italic> in domestic cats in the central-western region of Brazil</article-title><source>Braz. J. Microbiol.</source><year>2014</year><volume>45</volume><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822014000200036</pub-id><pub-id pub-id-type="pmid">25242952</pub-id>
</element-citation></ref><ref id="B3-vetsci-11-00624"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bouza-Mora</surname><given-names>L.</given-names></name>
<name><surname>Dolz</surname><given-names>G.</given-names></name>
<name><surname>Sol&#x000f3;rzano-Morales</surname><given-names>A.</given-names></name>
<name><surname>Romero-Zu&#x000f1;iga</surname><given-names>J.J.</given-names></name>
<name><surname>Salazar-S&#x000e1;nchez</surname><given-names>L.</given-names></name>
<name><surname>Labruna</surname><given-names>M.B.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Novel genotype of <italic toggle="yes">Ehrlichia canis</italic> detected in samples of human blood bank donors in Costa Rica</article-title><source>Ticks Tick Borne Dis.</source><year>2017</year><volume>81</volume><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.ttbdis.2016.09.012</pub-id><pub-id pub-id-type="pmid">27682202</pub-id>
</element-citation></ref><ref id="B4-vetsci-11-00624"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Braga</surname><given-names>&#x000cd;.A.</given-names></name>
<name><surname>Taques</surname><given-names>I.I.G.G.</given-names></name>
<name><surname>Grontoski</surname><given-names>E.C.</given-names></name>
<name><surname>Dias</surname><given-names>I.S.O.</given-names></name>
<name><surname>Pereira</surname><given-names>N.A.</given-names></name>
<name><surname>Ramos</surname><given-names>D.G.S.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Exposure of domestic cats to distinct <italic toggle="yes">Ehrlichia canis</italic> TRP genotypes</article-title><source>Vet. Sci.</source><year>2021</year><volume>8</volume><elocation-id>310</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci8120310</pub-id><pub-id pub-id-type="pmid">34941837</pub-id>
</element-citation></ref><ref id="B5-vetsci-11-00624"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salje</surname><given-names>J.</given-names></name>
</person-group><article-title>Cells within cells: Rickettsiales and the obligate intracellular bacterial lifestyle</article-title><source>Nat. Rev. Microbiol.</source><year>2021</year><volume>19</volume><fpage>375</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1038/s41579-020-00507-2</pub-id><pub-id pub-id-type="pmid">33564174</pub-id>
</element-citation></ref><ref id="B6-vetsci-11-00624"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Schaik</surname><given-names>E.J.</given-names></name>
<name><surname>Fratzke</surname><given-names>A.P.</given-names></name>
<name><surname>Gregory</surname><given-names>A.E.</given-names></name>
<name><surname>Dumaine</surname><given-names>J.E.</given-names></name>
<name><surname>Samuel</surname><given-names>J.E.</given-names></name>
</person-group><article-title>Vaccine development: Obligate intracellular bacteria new tools, old pathogens: The current state of vaccines against obligate intracellular bacteria</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2024</year><volume>14</volume><elocation-id>1282183</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2024.1282183</pub-id><pub-id pub-id-type="pmid">38567021</pub-id>
</element-citation></ref><ref id="B7-vetsci-11-00624"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Molecular and cellular pathobiology of <italic toggle="yes">Ehrlichia</italic> infection: Targets for new therapeutics and immunomodulation strategies</article-title><source>Expert Rev. Mol. Med.</source><year>2011</year><volume>13</volume><fpage>e3</fpage><pub-id pub-id-type="doi">10.1017/S1462399410001730</pub-id><pub-id pub-id-type="pmid">21276277</pub-id>
</element-citation></ref><ref id="B8-vetsci-11-00624"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Keysary</surname><given-names>A.</given-names></name>
<name><surname>Baneth</surname><given-names>G.</given-names></name>
<name><surname>Miyashiro</surname><given-names>S.</given-names></name>
<name><surname>Strenger</surname><given-names>C.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Genetic and antigenic diversities of major immunoreactive proteins in globally distributed <italic toggle="yes">Ehrlichia canis</italic> strains</article-title><source>Clin. Vaccine Immunol.</source><year>2008</year><volume>15</volume><fpage>1080</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1128/CVI.00482-07</pub-id><pub-id pub-id-type="pmid">18480237</pub-id>
</element-citation></ref><ref id="B9-vetsci-11-00624"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ali</surname><given-names>A.</given-names></name>
<name><surname>Ahmad</surname><given-names>S.</given-names></name>
<name><surname>Wadood</surname><given-names>A.</given-names></name>
<name><surname>Rehman</surname><given-names>A.U.</given-names></name>
<name><surname>Zahid</surname><given-names>H.</given-names></name>
<name><surname>Khan</surname><given-names>M.Q.</given-names></name>
<name><surname>Nawab</surname><given-names>J.</given-names></name>
<name><surname>Rahman</surname><given-names>Z.U.</given-names></name>
<name><surname>Alouffi</surname><given-names>A.S.</given-names></name>
</person-group><article-title>Modeling novel putative drugs and vaccine candidates against tick-borne pathogens: A subtractive proteomics approach</article-title><source>Vet. Sci.</source><year>2020</year><volume>7</volume><elocation-id>129</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci7030129</pub-id><pub-id pub-id-type="pmid">32906620</pub-id>
</element-citation></ref><ref id="B10-vetsci-11-00624"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khan</surname><given-names>M.A.</given-names></name>
<name><surname>Amin</surname><given-names>A.</given-names></name>
<name><surname>Farid</surname><given-names>A.</given-names></name>
<name><surname>Ullah</surname><given-names>A.</given-names></name>
<name><surname>Waris</surname><given-names>A.</given-names></name>
<name><surname>Shinwari</surname><given-names>K.</given-names></name>
<name><surname>Khan</surname><given-names>H.</given-names></name>
</person-group><article-title>Recent advances in genomics-based approaches for the development of intracellular bacterial pathogen vaccines</article-title><source>Pharmaceutics</source><year>2022</year><volume>15</volume><elocation-id>152</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15010152</pub-id><pub-id pub-id-type="pmid">36678781</pub-id>
</element-citation></ref><ref id="B11-vetsci-11-00624"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sabzi</surname><given-names>S.</given-names></name>
<name><surname>Shahbazi</surname><given-names>S.</given-names></name>
<name><surname>Noori Goodarzi</surname><given-names>N.</given-names></name>
<name><surname>Haririzadeh Jouriani</surname><given-names>F.</given-names></name>
<name><surname>Habibi</surname><given-names>M.</given-names></name>
<name><surname>Bolourchi</surname><given-names>N.</given-names></name>
<name><surname>Badmasti</surname><given-names>F.</given-names></name>
</person-group><article-title>Genome-wide subtraction analysis and reverse vaccinology to detect novel drug targets and potential vaccine candidates against <italic toggle="yes">Ehrlichia chaffeensis</italic></article-title><source>Appl. Biochem. Biotechnol.</source><year>2023</year><volume>195</volume><fpage>107</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1007/s12010-022-04116-y</pub-id><pub-id pub-id-type="pmid">36053401</pub-id>
</element-citation></ref><ref id="B12-vetsci-11-00624"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Patel</surname><given-names>J.G.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia chaffeensis</italic> and <italic toggle="yes">E. canis</italic> hypothetical protein immunoanalysis reveals small secreted immunodominant proteins and conformation-dependent antibody epitopes</article-title><source>NPJ Vaccines</source><year>2020</year><volume>5</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1038/s41541-020-00231-1</pub-id><pub-id pub-id-type="pmid">32963815</pub-id>
</element-citation></ref><ref id="B13-vetsci-11-00624"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Patel</surname><given-names>J.G.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Immunoreactive protein repertoires of <italic toggle="yes">Ehrlichia chaffeensis</italic> and <italic toggle="yes">E. canis</italic> reveal the dominance of hypothetical proteins and conformation-dependent antibody epitopes</article-title><source>Infect. Immun.</source><year>2021</year><volume>89</volume><fpage>e00224-21</fpage><pub-id pub-id-type="doi">10.1128/IAI.00224-21</pub-id><pub-id pub-id-type="pmid">34370510</pub-id>
</element-citation></ref><ref id="B14-vetsci-11-00624"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Patel</surname><given-names>J.G.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Antibody reactive immunomes of <italic toggle="yes">Ehrlichia chaffeensis</italic> and <italic toggle="yes">E. canis</italic> are diverse and defined by conformational antigenic determinants</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2024</year><volume>13</volume><elocation-id>1321291</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1321291</pub-id><pub-id pub-id-type="pmid">38264730</pub-id>
</element-citation></ref><ref id="B15-vetsci-11-00624"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diniz</surname><given-names>P.P.V.P.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Ehrlichiosis and Anaplasmosis: An Update</article-title><source>Vet. Clin. N. Am. Small Anim. Pract.</source><year>2022</year><volume>52</volume><fpage>1225</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1016/j.cvsm.2022.07.002</pub-id></element-citation></ref><ref id="B16-vetsci-11-00624"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chaber</surname><given-names>A.L.</given-names></name>
<name><surname>Easther</surname><given-names>R.</given-names></name>
<name><surname>Cumming</surname><given-names>B.</given-names></name>
<name><surname>Irving</surname><given-names>R.</given-names></name>
<name><surname>Keyburn</surname><given-names>A.L.</given-names></name>
<name><surname>Smart</surname><given-names>C.</given-names></name>
<name><surname>O&#x02019;Handley</surname><given-names>R.</given-names></name>
<name><surname>Lignereux</surname><given-names>L.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia canis</italic> rapid spread and possible enzooty in northern South Australia and distribution of its vector <italic toggle="yes">Rhipicephalus linnaei</italic></article-title><source>Aust. Vet. J.</source><year>2022</year><volume>100</volume><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1111/avj.13201</pub-id><pub-id pub-id-type="pmid">36053779</pub-id>
</element-citation></ref><ref id="B17-vetsci-11-00624"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stich</surname><given-names>R.W.</given-names></name>
<name><surname>Schaefer</surname><given-names>J.J.</given-names></name>
<name><surname>Bremer</surname><given-names>W.G.</given-names></name>
<name><surname>Needham</surname><given-names>G.R.</given-names></name>
<name><surname>Jittapalapong</surname><given-names>S.</given-names></name>
</person-group><article-title>Host surveys, ixodid tick biology and transmission scenarios as related to the tick-borne pathogen, <italic toggle="yes">Ehrlichia canis</italic></article-title><source>Vet. Parasitol.</source><year>2008</year><volume>158</volume><fpage>256</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2008.09.013</pub-id><pub-id pub-id-type="pmid">18963493</pub-id>
</element-citation></ref><ref id="B18-vetsci-11-00624"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bremer</surname><given-names>W.G.</given-names></name>
<name><surname>Schaefer</surname><given-names>J.J.</given-names></name>
<name><surname>Wagner</surname><given-names>E.R.</given-names></name>
<name><surname>Ewing</surname><given-names>S.A.</given-names></name>
<name><surname>Rikihisa</surname><given-names>Y.</given-names></name>
<name><surname>Needham</surname><given-names>G.R.</given-names></name>
<name><surname>Jittapalapong</surname><given-names>S.</given-names></name>
<name><surname>Moore</surname><given-names>D.L.</given-names></name>
<name><surname>Stich</surname><given-names>R.W.</given-names></name>
</person-group><article-title>Transstadial and intrastadial experimental transmission of <italic toggle="yes">Ehrlichia canis</italic> by male <italic toggle="yes">Rhipicephalus sanguineus</italic></article-title><source>Vet. Parasitol.</source><year>2005</year><volume>131</volume><fpage>95</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2005.04.030</pub-id><pub-id pub-id-type="pmid">15941624</pub-id>
</element-citation></ref><ref id="B19-vetsci-11-00624"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saito</surname><given-names>T.B.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Ehrlichioses: An Important One Health Opportunity</article-title><source>Vet. Sci.</source><year>2016</year><volume>3</volume><elocation-id>20</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci3030020</pub-id><pub-id pub-id-type="pmid">29056728</pub-id>
</element-citation></ref><ref id="B20-vetsci-11-00624"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maggi</surname><given-names>R.G.</given-names></name>
<name><surname>Kr&#x000e4;mer</surname><given-names>F.</given-names></name>
</person-group><article-title>A review on the occurrence of companion vector-borne diseases in pet animals in Latin America</article-title><source>Parasit. Vectors</source><year>2019</year><volume>12</volume><fpage>145</fpage><pub-id pub-id-type="doi">10.1186/s13071-019-3407-x</pub-id><pub-id pub-id-type="pmid">30917860</pub-id>
</element-citation></ref><ref id="B21-vetsci-11-00624"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mir&#x000f3;</surname><given-names>G.</given-names></name>
<name><surname>Wright</surname><given-names>I.</given-names></name>
<name><surname>Michael</surname><given-names>H.</given-names></name>
<name><surname>Burton</surname><given-names>W.</given-names></name>
<name><surname>Hegarty</surname><given-names>E.</given-names></name>
<name><surname>Rod&#x000f3;n</surname><given-names>J.</given-names></name>
<name><surname>Buch</surname><given-names>J.</given-names></name>
<name><surname>Pantchev</surname><given-names>N.</given-names></name>
<name><surname>von Samson Himmelstjerna</surname><given-names>G.</given-names></name>
</person-group><article-title>Seropositivity of main vector-borne pathogens in dogs across Europe</article-title><source>Parasit. Vectors</source><year>2022</year><volume>15</volume><fpage>189</fpage><pub-id pub-id-type="doi">10.1186/s13071-022-05316-5</pub-id><pub-id pub-id-type="pmid">35668469</pub-id>
</element-citation></ref><ref id="B22-vetsci-11-00624"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>R.</given-names></name>
<name><surname>Cerqueira</surname><given-names>A.</given-names></name>
<name><surname>Castro</surname><given-names>T.</given-names></name>
<name><surname>Ferreira</surname><given-names>E.</given-names></name>
<name><surname>Neves</surname><given-names>F.</given-names></name>
<name><surname>Barbosa</surname><given-names>A.</given-names></name>
<name><surname>Macieira</surname><given-names>D.</given-names></name>
<name><surname>Almosny</surname><given-names>N.</given-names></name>
</person-group><article-title>Genetic diversity of <italic toggle="yes">Ehrlichia canis</italic> strains from naturally infected dogs in Rio de Janeiro, Brazil</article-title><source>Braz. Jn. Vet. Parasitol.</source><year>2014</year><volume>23</volume><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1590/S1984-29612014055</pub-id><pub-id pub-id-type="pmid">25271448</pub-id>
</element-citation></ref><ref id="B23-vetsci-11-00624"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Judy</surname><given-names>L.</given-names></name>
<name><surname>David</surname><given-names>K.</given-names></name>
<name><surname>Peter</surname><given-names>K.</given-names></name>
<name><surname>Dhaval</surname><given-names>S.</given-names></name>
</person-group><article-title>Canine ehrlichiosis seropositivity and associated factors in Kenya and Tanzania: A retrospective study</article-title><source>BMC Vet. Res.</source><year>2023</year><volume>19</volume><elocation-id>175</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-023-03746-6</pub-id><pub-id pub-id-type="pmid">37770863</pub-id>
</element-citation></ref><ref id="B24-vetsci-11-00624"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alc&#x000f3;n-Chino</surname><given-names>M.E.</given-names></name>
<name><surname>De-Simone</surname><given-names>S.G.</given-names></name>
</person-group><article-title>Advancements in Understanding and Diagnosing Canine Ehrlichiosis: A Comprehensive Review</article-title><source>Preprints</source><year>2024</year><pub-id pub-id-type="doi">10.20944/preprints202404.0490.v1</pub-id></element-citation></ref><ref id="B25-vetsci-11-00624"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Szab&#x000f3;</surname><given-names>M.P.J.</given-names></name>
<name><surname>Mangold</surname><given-names>A.J.</given-names></name>
<name><surname>Jo&#x000e3;o</surname><given-names>C.F.</given-names></name>
<name><surname>Bechara</surname><given-names>G.H.</given-names></name>
<name><surname>Guglielmone</surname><given-names>A.A.</given-names></name>
</person-group><article-title>Biological and DNA evidence of two dissimilar populations of the <italic toggle="yes">Rhipicephalus sanguineus</italic> tick group (Acari: Ixodidae) in South America</article-title><source>Vet. Parasitol.</source><year>2005</year><volume>130</volume><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2005.03.008</pub-id><pub-id pub-id-type="pmid">15893080</pub-id>
</element-citation></ref><ref id="B26-vetsci-11-00624"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moraes-Filho</surname><given-names>J.</given-names></name>
<name><surname>Marcili</surname><given-names>A.</given-names></name>
<name><surname>Nieri-Bastos</surname><given-names>F.A.</given-names></name>
<name><surname>Richtzenhain</surname><given-names>L.J.</given-names></name>
<name><surname>Labruna</surname><given-names>M.B.</given-names></name>
</person-group><article-title>Genetic analysis of ticks belonging to the <italic toggle="yes">Rhipicephalus sanguineus</italic> group in Latin America</article-title><source>Acta Trop.</source><year>2011</year><volume>117</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.actatropica.2010.09.006</pub-id><pub-id pub-id-type="pmid">20858451</pub-id>
</element-citation></ref><ref id="B27-vetsci-11-00624"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dantas-Torres</surname><given-names>F.</given-names></name>
<name><surname>Latrofa</surname><given-names>M.S.</given-names></name>
<name><surname>Annoscia</surname><given-names>G.</given-names></name>
<name><surname>Giannelli</surname><given-names>A.</given-names></name>
<name><surname>Parisi</surname><given-names>A.</given-names></name>
</person-group><article-title>Morphological and genetic diversity of <italic toggle="yes">Rhipicephalus sanguineus</italic> sensu lato from the New and Old Worlds</article-title><source>Parasit. Vectors</source><year>2013</year><volume>6</volume><fpage>213</fpage><pub-id pub-id-type="doi">10.1186/1756-3305-6-213</pub-id><pub-id pub-id-type="pmid">23880226</pub-id>
</element-citation></ref><ref id="B28-vetsci-11-00624"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Latrofa</surname><given-names>M.S.</given-names></name>
<name><surname>Dantas-Torres</surname><given-names>F.</given-names></name>
<name><surname>Annoscia</surname><given-names>G.</given-names></name>
<name><surname>Cantacess</surname><given-names>C.</given-names></name>
<name><surname>Otranto</surname><given-names>D.</given-names></name>
</person-group><article-title>Comparative analyses of mitochondrial and nuclear genetic markers for the molecular identification of <italic toggle="yes">Rhipicephalus</italic> spp</article-title><source>Infect. Genet. Evol.</source><year>2013</year><volume>20</volume><fpage>422</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2013.09.027</pub-id><pub-id pub-id-type="pmid">24103336</pub-id>
</element-citation></ref><ref id="B29-vetsci-11-00624"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hekimo&#x0011f;lu</surname><given-names>O.</given-names></name>
</person-group><article-title>An update on the phylogeny and biogeographical history of <italic toggle="yes">Rhipicephalus sanguineus</italic> complex</article-title><source>Turk. J. Zool.</source><year>2024</year><volume>48</volume><fpage>21</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.55730/1300-0179.3157</pub-id></element-citation></ref><ref id="B30-vetsci-11-00624"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moraes-Filho</surname><given-names>J.</given-names></name>
<name><surname>Krawczak</surname><given-names>F.S.</given-names></name>
<name><surname>Costa</surname><given-names>F.B.</given-names></name>
<name><surname>Soares</surname><given-names>J.F.</given-names></name>
<name><surname>Labruna</surname><given-names>M.B.</given-names></name>
</person-group><article-title>Comparative Evaluation of the Vector Competence of Four South American Populations of the <italic toggle="yes">Rhipicephalus sanguineus</italic> Group for the Bacterium <italic toggle="yes">Ehrlichia canis</italic>, the Agent of Canine Monocytic Ehrlichiosis</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0139386</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0139386</pub-id><pub-id pub-id-type="pmid">26414283</pub-id>
</element-citation></ref><ref id="B31-vetsci-11-00624"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanches</surname><given-names>G.S.</given-names></name>
<name><surname>Villar</surname><given-names>M.</given-names></name>
<name><surname>Couto</surname><given-names>J.</given-names></name>
<name><surname>Ferrolho</surname><given-names>J.</given-names></name>
<name><surname>Fern&#x000e1;ndez de Mera</surname><given-names>I.G.</given-names></name>
<name><surname>Andr&#x000e9;</surname><given-names>M.R.</given-names></name>
<name><surname>Barros-Battesti</surname><given-names>D.M.</given-names></name>
<name><surname>Machado</surname><given-names>R.Z.</given-names></name>
<name><surname>Bechara</surname><given-names>G.H.</given-names></name>
<name><surname>Mateos-Hern&#x000e1;ndez</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Comparative Proteomic Analysis of <italic toggle="yes">Rhipicephalus sanguineus</italic> sensu lato (Acari: Ixodidae) Tropical and Temperate Lineages: Uncovering Differences During <italic toggle="yes">Ehrlichia canis</italic> Infection</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2021</year><volume>10</volume><elocation-id>611113</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2020.611113</pub-id><pub-id pub-id-type="pmid">33585280</pub-id>
</element-citation></ref><ref id="B32-vetsci-11-00624"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castro</surname><given-names>M.B.</given-names></name>
<name><surname>Machado</surname><given-names>R.Z.</given-names></name>
<name><surname>Aquino</surname><given-names>L.P.</given-names></name>
<name><surname>Alessi</surname><given-names>A.C.</given-names></name>
<name><surname>Costa</surname><given-names>M.T.</given-names></name>
</person-group><article-title>Experimental acute canine monocytic ehrlichiosis: Clinicopathological and immunopathological findings</article-title><source>Vet. Parasitol.</source><year>2004</year><volume>119</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2003.10.012</pub-id><pub-id pub-id-type="pmid">15036578</pub-id>
</element-citation></ref><ref id="B33-vetsci-11-00624"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mylonakis</surname><given-names>M.E.</given-names></name>
<name><surname>Koutinas</surname><given-names>A.F.</given-names></name>
<name><surname>Breitschwerdt</surname><given-names>E.B.</given-names></name>
<name><surname>Hegarty</surname><given-names>B.C.</given-names></name>
<name><surname>Billinis</surname><given-names>C.D.</given-names></name>
<name><surname>Leontides</surname><given-names>L.S.</given-names></name>
<name><surname>Kontos</surname><given-names>V.S.</given-names></name>
</person-group><article-title>Chronic canine ehrlichiosis (<italic toggle="yes">Ehrlichia canis</italic>): A retrospective study of 19 natural cases</article-title><source>J. Am. Anim. Hosp. Assoc.</source><year>2004</year><volume>40</volume><fpage>174</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.5326/0400174</pub-id><pub-id pub-id-type="pmid">15131097</pub-id>
</element-citation></ref><ref id="B34-vetsci-11-00624"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Melo</surname><given-names>A.L.</given-names></name>
<name><surname>Pacheco</surname><given-names>T.A.</given-names></name>
<name><surname>Meneses</surname><given-names>A.M.</given-names></name>
<name><surname>Zanutto</surname><given-names>M.S.</given-names></name>
<name><surname>Horta</surname><given-names>M.C.</given-names></name>
<name><surname>Santar&#x000e9;m</surname><given-names>V.A.</given-names></name>
<name><surname>Camargo</surname><given-names>L.M.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<etal/>
</person-group><article-title>Genetic diversity of <italic toggle="yes">Ehrlichia canis</italic> in Brazil</article-title><source>Vet. Microbiol.</source><year>2013</year><volume>164</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2013.02.015</pub-id><pub-id pub-id-type="pmid">23490559</pub-id>
</element-citation></ref><ref id="B35-vetsci-11-00624"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
<name><surname>Melo</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Divergence of the TRP36 protein (gp36) in <italic toggle="yes">Ehrlichia canis</italic> strains found in Brazil</article-title><source>Ticks Tick Borne Dis.</source><year>2015</year><volume>6</volume><fpage>103</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.ttbdis.2014.10.003</pub-id><pub-id pub-id-type="pmid">25467070</pub-id>
</element-citation></ref><ref id="B36-vetsci-11-00624"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hsieh</surname><given-names>Y.C.</given-names></name>
<name><surname>Lee</surname><given-names>C.C.</given-names></name>
<name><surname>Tsang</surname><given-names>C.L.</given-names></name>
<name><surname>Chung</surname><given-names>Y.T.</given-names></name>
</person-group><article-title>Detection and characterization of four novel genotypes of <italic toggle="yes">Ehrlichia canis</italic> from dogs</article-title><source>Vet. Microbiol.</source><year>2010</year><volume>146</volume><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2010.04.013</pub-id><pub-id pub-id-type="pmid">20451333</pub-id>
</element-citation></ref><ref id="B37-vetsci-11-00624"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Navarrete</surname><given-names>M.G.</given-names></name>
<name><surname>Hod&#x0017e;i&#x00107;</surname><given-names>A.</given-names></name>
<name><surname>Corona-Gonz&#x000e1;lez</surname><given-names>B.</given-names></name>
<name><surname>Cordeiro</surname><given-names>M.D.</given-names></name>
<name><surname>da Silva</surname><given-names>C.B.</given-names></name>
<name><surname>B&#x000e1;ez</surname><given-names>L.C.</given-names></name>
<name><surname>Cabezas-Cruz</surname><given-names>A.</given-names></name>
</person-group><article-title>Novo genogrupo <italic toggle="yes">de Ehrlichia canis</italic> em c&#x000e3;es com ehrlichiose canina em Cuba</article-title><source>Parasit. Vectors</source><year>2022</year><volume>15</volume><fpage>295</fpage><pub-id pub-id-type="doi">10.1186/s13071-022-05426-0</pub-id><pub-id pub-id-type="pmid">35999566</pub-id>
</element-citation></ref><ref id="B38-vetsci-11-00624"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zweygarth</surname><given-names>E.</given-names></name>
<name><surname>Cabezas-Cruz</surname><given-names>A.</given-names></name>
<name><surname>Josemans</surname><given-names>A.I.</given-names></name>
<name><surname>Oosthuizen</surname><given-names>M.C.</given-names></name>
<name><surname>Matjila</surname><given-names>P.T.</given-names></name>
<name><surname>Lis</surname><given-names>K.</given-names></name>
<name><surname>Broniszewska</surname><given-names>M.</given-names></name>
<name><surname>Sch&#x000f6;l</surname><given-names>H.</given-names></name>
<name><surname>Ferrolho</surname><given-names>J.</given-names></name>
<name><surname>Grubhoffer</surname><given-names>L.M.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">In vitro</italic> culture and structural differences in the major immunoreactive protein gp36 of geographically distant <italic toggle="yes">Ehrlichia canis</italic> isolates</article-title><source>Ticks Tick Borne Dis.</source><year>2014</year><volume>5</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1016/j.ttbdis.2014.01.011</pub-id><pub-id pub-id-type="pmid">24713279</pub-id>
</element-citation></ref><ref id="B39-vetsci-11-00624"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aktas</surname><given-names>M.</given-names></name>
<name><surname>&#x000d6;z&#x000fc;bek</surname><given-names>S.</given-names></name>
</person-group><article-title>Genetic diversity of <italic toggle="yes">Ehrlichia canis</italic> in dogs from Turkey inferred by TRP36 sequence analysis and phylogeny</article-title><source>Comp. Immunol. Microbiol. Infect. Dis.</source><year>2019</year><volume>64</volume><fpage>20</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.cimid.2019.02.003</pub-id><pub-id pub-id-type="pmid">31174695</pub-id>
</element-citation></ref><ref id="B40-vetsci-11-00624"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taques</surname><given-names>I.I.G.G.</given-names></name>
<name><surname>Campos</surname><given-names>A.N.S.</given-names></name>
<name><surname>Kavasaki</surname><given-names>M.L.</given-names></name>
<name><surname>de Almeida</surname><given-names>S.L.H.</given-names></name>
<name><surname>de Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Geographic Distribution of <italic toggle="yes">Ehrlichia canis</italic> TRP Genotypes in Brazil</article-title><source>Vet. Sci.</source><year>2020</year><volume>7</volume><elocation-id>165</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci7040165</pub-id><pub-id pub-id-type="pmid">33138252</pub-id>
</element-citation></ref><ref id="B41-vetsci-11-00624"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borges</surname><given-names>K.I.N.</given-names></name>
<name><surname>Pereira</surname><given-names>N.d.A.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
<name><surname>Taques</surname><given-names>I.I.G.G.</given-names></name>
<name><surname>Alves-Ribeiro</surname><given-names>B.S.</given-names></name>
<name><surname>Ramos</surname><given-names>D.G.S.</given-names></name>
<name><surname>Braga</surname><given-names>&#x000cd;.A.</given-names></name>
</person-group><article-title>Costa Rican Genotype of <italic toggle="yes">Ehrlichia canis</italic>: A Current Concern</article-title><source>Vet. Sci.</source><year>2023</year><volume>10</volume><elocation-id>316</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci10050316</pub-id><pub-id pub-id-type="pmid">37235399</pub-id>
</element-citation></ref><ref id="B42-vetsci-11-00624"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arroyave</surname><given-names>E.</given-names></name>
<name><surname>Rodas-Gonz&#x000e1;lez</surname><given-names>J.D.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Labruna</surname><given-names>M.B.</given-names></name>
<name><surname>Gonz&#x000e1;lez</surname><given-names>M.S.</given-names></name>
<name><surname>Fern&#x000e1;ndez-Silva</surname><given-names>J.A.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia canis</italic> TRP36 diversity in naturally infected-dogs from an urban area of Colombia</article-title><source>Ticks Tick Borne Dis.</source><year>2020</year><volume>11</volume><fpage>101367</fpage><pub-id pub-id-type="doi">10.1016/j.ttbdis.2019.101367</pub-id><pub-id pub-id-type="pmid">31987818</pub-id>
</element-citation></ref><ref id="B43-vetsci-11-00624"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taques</surname><given-names>I.I.G.G.</given-names></name>
<name><surname>Koiyama</surname><given-names>M.F.G.</given-names></name>
<name><surname>Campos</surname><given-names>A.N.S.</given-names></name>
<name><surname>Costa</surname><given-names>J.S.</given-names></name>
<name><surname>Hongyu</surname><given-names>K.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Canonical correlative analyses among an enzyme-linked immunosorbent assay using synthetic peptides, an indirect fluorescent antibody test, and hematologic measurements in dogs infected with <italic toggle="yes">Ehrlichia canis</italic></article-title><source>Vet. Clin. Pathol.</source><year>2020</year><volume>49</volume><fpage>574</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1111/vcp.12908</pub-id><pub-id pub-id-type="pmid">33135177</pub-id>
</element-citation></ref><ref id="B44-vetsci-11-00624"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zorzo</surname><given-names>C.</given-names></name>
<name><surname>Pereira</surname><given-names>N.A.</given-names></name>
<name><surname>Hongyu</surname><given-names>K.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Correlation between canine biochemical analytes and TRP36 ELISA seropositivity for <italic toggle="yes">Ehrlichia canis</italic> in Brazil</article-title><source>Vet. Clin. Pathol.</source><year>2023</year><volume>52</volume><fpage>621</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1111/vcp.13277</pub-id><pub-id pub-id-type="pmid">37488073</pub-id>
</element-citation></ref><ref id="B45-vetsci-11-00624"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lorente</surname><given-names>C.</given-names></name>
<name><surname>Sainz</surname><given-names>A.</given-names></name>
<name><surname>Tesouro</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Immunophenotype of dogs with subclinical ehrlichiosis</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2008</year><volume>1149</volume><fpage>114</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1196/annals.1428.040</pub-id><pub-id pub-id-type="pmid">19120187</pub-id>
</element-citation></ref><ref id="B46-vetsci-11-00624"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wikel</surname><given-names>S.K.</given-names></name>
</person-group><article-title>Tick modulation of host immunity: An important factor in pathogen transmission</article-title><source>Int. J. Parasitol.</source><year>1999</year><volume>29</volume><fpage>851</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1016/S0020-7519(99)00042-9</pub-id><pub-id pub-id-type="pmid">10480722</pub-id>
</element-citation></ref><ref id="B47-vetsci-11-00624"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rikihisa</surname><given-names>Y.</given-names></name>
</person-group><article-title>Molecular events involved in cellular invasion by <italic toggle="yes">Ehrlichia chaffeensis</italic> and <italic toggle="yes">Anaplasma phagocytophilum</italic></article-title><source>Vet. Parasitol.</source><year>2010</year><volume>167</volume><fpage>155</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2009.09.017</pub-id><pub-id pub-id-type="pmid">19836896</pub-id>
</element-citation></ref><ref id="B48-vetsci-11-00624"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.Z.</given-names></name>
<name><surname>Sinha</surname><given-names>M.</given-names></name>
<name><surname>Luxon</surname><given-names>B.A.</given-names></name>
<name><surname>Yu</surname><given-names>X.J.</given-names></name>
</person-group><article-title>Survival strategy of obligately intracellular <italic toggle="yes">Ehrlichia chaffeensis</italic>: Novel modulation of immune response and host cell cycles</article-title><source>Infect. Immun.</source><year>2004</year><volume>72</volume><fpage>498</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1128/IAI.72.1.498-507.2004</pub-id><pub-id pub-id-type="pmid">14688131</pub-id>
</element-citation></ref><ref id="B49-vetsci-11-00624"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tajima</surname><given-names>T.</given-names></name>
<name><surname>Wada</surname><given-names>M.</given-names></name>
</person-group><article-title>Inhibitory effect of interferon gamma on frequency of <italic toggle="yes">Ehrlichia canis</italic>-infected cells <italic toggle="yes">in vitro</italic></article-title><source>Vet. Immunol. Immunopathol.</source><year>2013</year><volume>156</volume><fpage>200</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2013.09.014</pub-id><pub-id pub-id-type="pmid">24148826</pub-id>
</element-citation></ref><ref id="B50-vetsci-11-00624"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<name><surname>Corstvet</surname><given-names>R.E.</given-names></name>
<name><surname>Gaunt</surname><given-names>S.D.</given-names></name>
<name><surname>Boudreaux</surname><given-names>C.</given-names></name>
<name><surname>Guedry</surname><given-names>T.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Kinetics of Antibody Response to <italic toggle="yes">Ehrlichia canis</italic> Immunoreactive Proteins</article-title><source>Infect. Immun.</source><year>2003</year><volume>71</volume><fpage>2516</fpage><lpage>2524</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.5.2516-2524.2003</pub-id><pub-id pub-id-type="pmid">12704123</pub-id>
</element-citation></ref><ref id="B51-vetsci-11-00624"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allerton</surname><given-names>F.</given-names></name>
<name><surname>Prior</surname><given-names>C.</given-names></name>
<name><surname>Bagcigil</surname><given-names>A.F.</given-names></name>
<name><surname>Broens</surname><given-names>E.</given-names></name>
<name><surname>Callens</surname><given-names>B.</given-names></name>
<name><surname>Damborg</surname><given-names>P.</given-names></name>
<name><surname>Dewulf</surname><given-names>J.</given-names></name>
<name><surname>Filippitzi</surname><given-names>M.E.</given-names></name>
<name><surname>Carmo</surname><given-names>L.P.</given-names></name>
<name><surname>G&#x000f3;mez-Raja</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Overview and evaluation of existing guidelines for rational antimicrobial use in small-animal veterinary practice in Europe</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>409</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10040409</pub-id><pub-id pub-id-type="pmid">33918617</pub-id>
</element-citation></ref><ref id="B52-vetsci-11-00624"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ros&#x000e1;rio</surname><given-names>C.J.R.M.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
<name><surname>Lima</surname><given-names>C.A.A.</given-names></name>
<name><surname>Coutinho</surname><given-names>D.F.</given-names></name>
<name><surname>Pereira</surname><given-names>J.G.</given-names></name>
<name><surname>Melo</surname><given-names>F.A.</given-names></name>
<name><surname>Rocha</surname><given-names>C.Q.</given-names></name>
</person-group><article-title>Association of polar fraction of <italic toggle="yes">Ageratum conyzoides</italic> from the Brazilian Amazon with doxycycline against infection of macrophages with <italic toggle="yes">Ehrlichia canis</italic></article-title><source>S. Afr. J. Bot.</source><year>2023</year><volume>155</volume><fpage>90</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2023.02.017</pub-id></element-citation></ref><ref id="B53-vetsci-11-00624"><label>53.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<name><surname>Chanda</surname><given-names>S.</given-names></name>
<name><surname>Rakholiya</surname><given-names>K.</given-names></name>
</person-group><article-title>Combination therapy: Synergism between natural plant extracts and antibiotics against infectious diseases</article-title><source>Science Against Microbial Pathogens: Communicating Current Research and Technological Advances</source><year>2011</year><fpage>520</fpage><lpage>529</lpage><comment>Available online: <ext-link xlink:href="https://www.researchgate.net/publication/268064090_Combination_therapy_Synergism_between_natural_plant_extracts_and_antibiotics_against_infectious_diseases" ext-link-type="uri">https://www.researchgate.net/publication/268064090_Combination_therapy_Synergism_between_natural_plant_extracts_and_antibiotics_against_infectious_diseases</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-02">(accessed on 2 December 2024)</date-in-citation></element-citation></ref><ref id="B54-vetsci-11-00624"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schaefer</surname><given-names>J.J.</given-names></name>
<name><surname>Needham</surname><given-names>G.R.</given-names></name>
<name><surname>Bremer</surname><given-names>W.G.</given-names></name>
<name><surname>Rikihisa</surname><given-names>Y.</given-names></name>
<name><surname>Ewing</surname><given-names>S.A.</given-names></name>
<name><surname>Stich</surname><given-names>R.W.</given-names></name>
</person-group><article-title>Tick acquisition of <italic toggle="yes">Ehrlichia canis</italic> from dogs treated with doxycycline hyclate</article-title><source>Antimicrob. Agents Chemother.</source><year>2007</year><volume>51</volume><fpage>3394</fpage><lpage>3396</lpage><pub-id pub-id-type="doi">10.1128/AAC.00358-07</pub-id><pub-id pub-id-type="pmid">17606682</pub-id>
</element-citation></ref><ref id="B55-vetsci-11-00624"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mylonakis</surname><given-names>M.E.</given-names></name>
<name><surname>Harrus</surname><given-names>S.</given-names></name>
<name><surname>Breitschwerdt</surname><given-names>E.B.</given-names></name>
</person-group><article-title>An update on the treatment of canine monocytic ehrlichiosis (<italic toggle="yes">Ehrlichia canis</italic>)</article-title><source>Vet. J.</source><year>2019</year><volume>246</volume><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.tvjl.2019.01.015</pub-id><pub-id pub-id-type="pmid">30902188</pub-id>
</element-citation></ref><ref id="B56-vetsci-11-00624"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sunkara</surname><given-names>P.</given-names></name>
<name><surname>Chennuru</surname><given-names>S.</given-names></name>
<name><surname>Krovvidi</surname><given-names>S.</given-names></name>
<name><surname>Chitichoti</surname><given-names>J.</given-names></name>
</person-group><article-title>Cypermethrin and ivermectin resistance in field populations of <italic toggle="yes">Rhipicephalus sanguineus</italic> sensu lato (Latrielle, 1806) collected from dogs in south India</article-title><source>Vet. Res. Commun.</source><year>2022</year><volume>46</volume><fpage>67</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1007/s11259-021-09830-2</pub-id><pub-id pub-id-type="pmid">34535851</pub-id>
</element-citation></ref><ref id="B57-vetsci-11-00624"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>S&#x000e1;nchez P&#x000e9;rez</surname><given-names>M.</given-names></name>
<name><surname>Feira Arroyo</surname><given-names>T.P.</given-names></name>
<name><surname>Venegas Barrera</surname><given-names>C.S.</given-names></name>
<name><surname>Sosa-Guti&#x000e9;rrez</surname><given-names>C.</given-names></name>
<name><surname>Torres</surname><given-names>J.</given-names></name>
<name><surname>Marrom</surname><given-names>K.A.</given-names></name>
<name><surname>Gordillo P&#x000e9;rez</surname><given-names>G.</given-names></name>
</person-group><article-title>Predicting the Impact of Climate Change on the Distribution of <italic toggle="yes">Rhipicephalus sanguineus</italic> in the Americas</article-title><source>Sustainability</source><year>2023</year><volume>15</volume><elocation-id>4557</elocation-id><pub-id pub-id-type="doi">10.3390/su15054557</pub-id></element-citation></ref><ref id="B58-vetsci-11-00624"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luzzi</surname><given-names>M.C.</given-names></name>
<name><surname>Carvalho</surname><given-names>L.A.L.</given-names></name>
<name><surname>Pinheiro</surname><given-names>D.G.</given-names></name>
<name><surname>Lima-Duarte</surname><given-names>L.</given-names></name>
<name><surname>Camargo</surname><given-names>J.V.</given-names></name>
<name><surname>Kishi</surname><given-names>L.T.</given-names></name>
<name><surname>Fernandes</surname><given-names>C.C.</given-names></name>
<name><surname>Machado</surname><given-names>R.Z.</given-names></name>
<name><surname>Soares</surname><given-names>J.F.</given-names></name>
<name><surname>Andr&#x000e9;</surname><given-names>M.R.</given-names></name>
<etal/>
</person-group><article-title>Analysis on the prokaryotic microbiome in females and embryonic cell cultures of <italic toggle="yes">Rhipicephalus sanguineus</italic> tropical and temperate lineages from two specific localities in Brazil</article-title><source>Rev. Bras. Parasitol. Vet.</source><year>2021</year><volume>30</volume><fpage>e005721</fpage><pub-id pub-id-type="doi">10.1590/s1984-29612021066</pub-id><pub-id pub-id-type="pmid">34378769</pub-id>
</element-citation></ref><ref id="B59-vetsci-11-00624"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ferrolho</surname><given-names>J.</given-names></name>
<name><surname>Antunes</surname><given-names>S.</given-names></name>
<name><surname>Sanches</surname><given-names>G.S.</given-names></name>
<name><surname>Couto</surname><given-names>J.</given-names></name>
<name><surname>&#x000c9;vora</surname><given-names>P.M.</given-names></name>
<name><surname>Rosa</surname><given-names>C.</given-names></name>
<name><surname>Andr&#x000e9;</surname><given-names>M.R.</given-names></name>
<name><surname>Machado</surname><given-names>R.Z.</given-names></name>
<name><surname>Bechara</surname><given-names>G.H.</given-names></name>
<name><surname>Domingos</surname><given-names>A.</given-names></name>
</person-group><article-title>Ferritin 1 silencing effect in <italic toggle="yes">Rhipicephalus sanguineus</italic> sensu lato (Acari: Ixodidae) during experimental infection with <italic toggle="yes">Ehrlichia canis</italic></article-title><source>Ticks Tick Borne Dis.</source><year>2017</year><volume>8</volume><fpage>174</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.ttbdis.2016.10.015</pub-id><pub-id pub-id-type="pmid">27825659</pub-id>
</element-citation></ref><ref id="B60-vetsci-11-00624"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<name><surname>Yu</surname><given-names>X.J.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Molecular cloning of the gene for a conserved major immunoreactive 28-kilodalton protein of <italic toggle="yes">Ehrlichia canis</italic>: A potential serodiagnostic antigen</article-title><source>Clin. Diagn. Lab. Immunol.</source><year>1999</year><volume>6</volume><fpage>392</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1128/CDLI.6.3.392-399.1999</pub-id><pub-id pub-id-type="pmid">10225842</pub-id>
</element-citation></ref><ref id="B61-vetsci-11-00624"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nethery</surname><given-names>K.A.</given-names></name>
<name><surname>Doyle</surname><given-names>C.K.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia canis</italic> gp200 contains dominant species-specific antibody epitopes in terminal acidic domains</article-title><source>Infect. Immun.</source><year>2007</year><volume>75</volume><fpage>4900</fpage><lpage>4908</lpage><pub-id pub-id-type="doi">10.1128/IAI.00041-07</pub-id><pub-id pub-id-type="pmid">17682040</pub-id>
</element-citation></ref><ref id="B62-vetsci-11-00624"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Doyle</surname><given-names>C.K.</given-names></name>
<name><surname>Cardenas</surname><given-names>A.M.</given-names></name>
<name><surname>Aguiar</surname><given-names>D.M.</given-names></name>
<name><surname>Labruna</surname><given-names>M.B.</given-names></name>
<name><surname>Ndip</surname><given-names>L.M.</given-names></name>
<name><surname>Yu</surname><given-names>X.</given-names></name>
<name><surname>Mcbride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Molecular Characterization of <italic toggle="yes">E. canis</italic> gp36 and <italic toggle="yes">E. chaffeensis</italic> gp47 Tandem Repeats among Isolates from Different Geographic Locations</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2005</year><volume>1063</volume><fpage>433</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1196/annals.1355.079</pub-id><pub-id pub-id-type="pmid">16481555</pub-id>
</element-citation></ref><ref id="B63-vetsci-11-00624"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<name><surname>Doyle</surname><given-names>C.K.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Cardenas</surname><given-names>A.M.</given-names></name>
<name><surname>Popov</surname><given-names>V.L.</given-names></name>
<name><surname>Nethery</surname><given-names>K.A.</given-names></name>
<name><surname>Woods</surname><given-names>M.E.</given-names></name>
</person-group><article-title>Identification of a Glycosylated <italic toggle="yes">Ehrlichia canis</italic> 19-Kilodalton Major Immunoreactive Protein with a Species-Specific Serine-Rich Glycopeptide Epitope</article-title><source>Infect. Immun.</source><year>2007</year><volume>75</volume><fpage>74</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1128/IAI.01494-06</pub-id><pub-id pub-id-type="pmid">17088359</pub-id>
</element-citation></ref><ref id="B64-vetsci-11-00624"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Dunphy</surname><given-names>P.S.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia chaffeensis</italic> Tandem Repeat Effector Targets Differentially Influence Infection</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2017</year><volume>7</volume><elocation-id>178</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00178</pub-id><pub-id pub-id-type="pmid">28553621</pub-id>
</element-citation></ref><ref id="B65-vetsci-11-00624"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bui</surname><given-names>D.C.</given-names></name>
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Type 1 secretion system and effectors in Rickettsiales</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2023</year><volume>13</volume><elocation-id>1175688</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2023.1175688</pub-id><pub-id pub-id-type="pmid">37256108</pub-id>
</element-citation></ref><ref id="B66-vetsci-11-00624"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Byerly</surname><given-names>C.D.</given-names></name>
<name><surname>Patterson</surname><given-names>L.L.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia</italic> TRP effectors: Moonlighting, mimicry and infection</article-title><source>Pathog. Dis.</source><year>2021</year><volume>79</volume><fpage>ftab026</fpage><pub-id pub-id-type="doi">10.1093/femspd/ftab026</pub-id><pub-id pub-id-type="pmid">33974702</pub-id>
</element-citation></ref><ref id="B67-vetsci-11-00624"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Doyle</surname><given-names>C.K.</given-names></name>
<name><surname>Nethery</surname><given-names>K.A.</given-names></name>
<name><surname>Popov</surname><given-names>V.L.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Differentially expressed and secreted major immunoreactive protein orthologs of <italic toggle="yes">Ehrlichia canis</italic> and <italic toggle="yes">E. chaffeensis</italic> elicit early antibody responses to epitopes on glycosylated tandem repeats</article-title><source>Infect. Immun.</source><year>2006</year><volume>74</volume><fpage>711</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1128/IAI.74.1.711-720.2006</pub-id><pub-id pub-id-type="pmid">16369028</pub-id>
</element-citation></ref><ref id="B68-vetsci-11-00624"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Progress and obstacles in vaccine development for the ehrlichioses</article-title><source>Expert Rev. Vaccines</source><year>2010</year><volume>9</volume><fpage>1071</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1586/erv.10.93</pub-id><pub-id pub-id-type="pmid">20822349</pub-id>
</element-citation></ref><ref id="B69-vetsci-11-00624"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>D.D.</given-names></name>
<name><surname>Racine</surname><given-names>R.</given-names></name>
<name><surname>Wittmer</surname><given-names>S.T.</given-names></name>
<name><surname>Harston</surname><given-names>L.</given-names></name>
<name><surname>Papillion</surname><given-names>A.M.</given-names></name>
<name><surname>Dishaw</surname><given-names>L.M.</given-names></name>
<name><surname>Winslow</surname><given-names>G.M.</given-names></name>
</person-group><article-title>The omentum is a site of protective IgM production during intracellular bacterial infection</article-title><source>Infect. Immun.</source><year>2015</year><volume>83</volume><fpage>2139</fpage><lpage>2147</lpage><pub-id pub-id-type="doi">10.1128/IAI.00295-15</pub-id><pub-id pub-id-type="pmid">25776744</pub-id>
</element-citation></ref><ref id="B70-vetsci-11-00624"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patel</surname><given-names>J.G.</given-names></name>
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Immuno- and expression analysis of <italic toggle="yes">Ehrlichia canis</italic> immunoreactive proteins</article-title><source>Front. Vet. Sci.</source><year>2024</year><volume>11</volume><elocation-id>1481934</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2024.1481934</pub-id><pub-id pub-id-type="pmid">39497741</pub-id>
</element-citation></ref><ref id="B71-vetsci-11-00624"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Immelman</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Ehrlichia canis</italic> infection (Tropical canine pancytopaenia or canine rickettsiosis)</article-title><source>J. S. Afr. Vet.</source><year>1973</year><volume>44</volume><fpage>241</fpage><lpage>245</lpage></element-citation></ref><ref id="B72-vetsci-11-00624"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Buhles</surname><given-names>W.C.</given-names><suffix>Jr.</suffix></name>
<name><surname>Huxsoll</surname><given-names>D.L.</given-names></name>
<name><surname>Ristic</surname><given-names>M.</given-names></name>
</person-group><article-title>Tropical canine pancytopenia: Clinical, hematologic, and serologic response of dogs to <italic toggle="yes">Ehrlichia canis</italic> infection, tetracycline therapy, and challenge inoculation</article-title><source>J. Infect. Dis.</source><year>1974</year><volume>130</volume><fpage>357</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1093/infdis/130.4.357</pub-id><pub-id pub-id-type="pmid">4140878</pub-id>
</element-citation></ref><ref id="B73-vetsci-11-00624"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weisiger</surname><given-names>R.M.</given-names></name>
<name><surname>Ristic</surname><given-names>M.</given-names></name>
<name><surname>Huxsoll</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Kinetics of antibody response to <italic toggle="yes">Ehrlichia canis</italic> assayed by the indirect fluorescent antibody method</article-title><source>Am. J. Vet. Res.</source><year>1975</year><volume>36</volume><fpage>689</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">49162</pub-id>
</element-citation></ref><ref id="B74-vetsci-11-00624"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harrus</surname><given-names>S.</given-names></name>
<name><surname>Waner</surname><given-names>T.</given-names></name>
<name><surname>Bark</surname><given-names>H.</given-names></name>
<name><surname>Jongejan</surname><given-names>F.</given-names></name>
<name><surname>Cornelissen</surname><given-names>A.W.</given-names></name>
</person-group><article-title>Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis</article-title><source>J. Clin. Microbiol.</source><year>1999</year><volume>37</volume><fpage>2745</fpage><lpage>2749</lpage><pub-id pub-id-type="doi">10.1128/JCM.37.9.2745-2749.1999</pub-id><pub-id pub-id-type="pmid">10449445</pub-id>
</element-citation></ref><ref id="B75-vetsci-11-00624"><label>75.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Ristic</surname><given-names>Y.</given-names></name>
<name><surname>Holland</surname><given-names>C.J.</given-names></name>
</person-group><source>Canine Ehrlichiosis, in Rickettsial and Chlamydial Diseases of Domestic Animals</source><person-group person-group-type="editor">
<name><surname>Woldenhiwet</surname><given-names>Z.</given-names></name>
<name><surname>Ristic</surname><given-names>M.</given-names></name>
</person-group><publisher-name>Pergamon Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc><year>1993</year></element-citation></ref><ref id="B76-vetsci-11-00624"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Breitschwerdt</surname><given-names>E.B.</given-names></name>
<name><surname>Hegarty</surname><given-names>B.C.</given-names></name>
<name><surname>Hancock</surname><given-names>S.I.</given-names></name>
</person-group><article-title>Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two <italic toggle="yes">Ehrlichia canis</italic> strains</article-title><source>Antimicrob. Agents Chemother.</source><year>1998</year><volume>42</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1128/AAC.42.2.362</pub-id><pub-id pub-id-type="pmid">9527787</pub-id>
</element-citation></ref><ref id="B77-vetsci-11-00624"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mahan</surname><given-names>S.</given-names></name>
<name><surname>Kelly</surname><given-names>P.J.</given-names></name>
<name><surname>Mahan</surname><given-names>S.M.</given-names></name>
</person-group><article-title>A preliminary study to evaluate the immune responses induced by immunization of dogs with inactivated <italic toggle="yes">Ehrlichia canis</italic> organisms</article-title><source>Onderstepoort J. Vet. Res.</source><year>2005</year><volume>72</volume><fpage>a207</fpage><pub-id pub-id-type="doi">10.4102/ojvr.v72i2.207</pub-id></element-citation></ref><ref id="B78-vetsci-11-00624"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Or</surname><given-names>M.</given-names></name>
<name><surname>Samish</surname><given-names>M.</given-names></name>
<name><surname>Waner</surname><given-names>T.</given-names></name>
<name><surname>Harrus</surname><given-names>S.</given-names></name>
</person-group><article-title>Attenuation of <italic toggle="yes">Ehrlichia canis</italic> by multiple passages in two different cultures</article-title><source>Clin. Microbiol. Infect.</source><year>2009</year><volume>15</volume><fpage>74</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2008.02195.x</pub-id><pub-id pub-id-type="pmid">19438628</pub-id>
</element-citation></ref><ref id="B79-vetsci-11-00624"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rudoler</surname><given-names>N.</given-names></name>
<name><surname>Baneth</surname><given-names>G.</given-names></name>
<name><surname>Eyal</surname><given-names>O.</given-names></name>
<name><surname>van Straten</surname><given-names>M.</given-names></name>
<name><surname>Harrus</surname><given-names>S.</given-names></name>
</person-group><article-title>Evaluation of an attenuated strain of <italic toggle="yes">Ehrlichia canis</italic> as a vaccine for canine monocytic ehrlichiosis</article-title><source>Vaccine</source><year>2012</year><volume>31</volume><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2012.10.003</pub-id><pub-id pub-id-type="pmid">23072894</pub-id>
</element-citation></ref><ref id="B80-vetsci-11-00624"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thomas</surname><given-names>S.</given-names></name>
<name><surname>Thirumalapura</surname><given-names>N.R.</given-names></name>
<name><surname>Crocquet-Valdes</surname><given-names>P.A.</given-names></name>
<name><surname>Luxon</surname><given-names>B.A.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Structure-based vaccines provide protection in a mouse model of ehrlichiosis</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e27981</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0027981</pub-id><pub-id pub-id-type="pmid">22114733</pub-id>
</element-citation></ref><ref id="B81-vetsci-11-00624"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bidmos</surname><given-names>F.A.</given-names></name>
<name><surname>Siris</surname><given-names>S.</given-names></name>
<name><surname>Gladstone</surname><given-names>C.A.</given-names></name>
<name><surname>Langford</surname><given-names>P.R.</given-names></name>
</person-group><article-title>Bacterial vaccine antigen discovery in the reverse vaccinology 2.0 Era: Progress and challenges</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>2315</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02315</pub-id><pub-id pub-id-type="pmid">30349542</pub-id>
</element-citation></ref><ref id="B82-vetsci-11-00624"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thirumalapura</surname><given-names>N.R.</given-names></name>
<name><surname>Crocquet-Valdes</surname><given-names>P.A.</given-names></name>
<name><surname>Saito</surname><given-names>T.B.</given-names></name>
<name><surname>Thomas</surname><given-names>S.</given-names></name>
<name><surname>McBride</surname><given-names>J.W.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Recombinant <italic toggle="yes">Ehrlichia</italic> P29 protein induces a protective immune response in a mouse model of ehrlichiosis</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>5960</fpage><lpage>5967</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2013.10.036</pub-id><pub-id pub-id-type="pmid">24144475</pub-id>
</element-citation></ref><ref id="B83-vetsci-11-00624"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crocquet-Valdes</surname><given-names>P.A.</given-names></name>
<name><surname>Thirumalapura</surname><given-names>N.R.</given-names></name>
<name><surname>Ismail</surname><given-names>N.</given-names></name>
<name><surname>Yu</surname><given-names>X.</given-names></name>
<name><surname>Saito</surname><given-names>T.B.</given-names></name>
<name><surname>Stevenson</surname><given-names>H.L.</given-names></name>
<name><surname>Walker</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Immunization with <italic toggle="yes">Ehrlichia</italic> P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis</article-title><source>Clin. Vaccine Immunol.</source><year>2011</year><volume>18</volume><fpage>2018</fpage><lpage>2025</lpage><pub-id pub-id-type="doi">10.1128/CVI.05292-11</pub-id><pub-id pub-id-type="pmid">22030371</pub-id>
</element-citation></ref><ref id="B84-vetsci-11-00624"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nambooppha</surname><given-names>B.</given-names></name>
<name><surname>Rittipornlertrak</surname><given-names>A.</given-names></name>
<name><surname>Tattiyapong</surname><given-names>M.</given-names></name>
<name><surname>Tangtrongsup</surname><given-names>S.</given-names></name>
<name><surname>Tiwananthagorn</surname><given-names>S.</given-names></name>
<name><surname>Chung</surname><given-names>Y.T.</given-names></name>
<name><surname>Sthitmatee</surname><given-names>N.</given-names></name>
</person-group><article-title>Two different genogroups of <italic toggle="yes">Ehrlichia canis</italic> from dogs in Thailand using immunodominant protein genes</article-title><source>Infect. Genet. Evol.</source><year>2018</year><volume>63</volume><fpage>116</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2018.05.027</pub-id><pub-id pub-id-type="pmid">29852293</pub-id>
</element-citation></ref><ref id="B85-vetsci-11-00624"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nambooppha</surname><given-names>B.</given-names></name>
<name><surname>Rittipornlertrak</surname><given-names>A.</given-names></name>
<name><surname>Muenthaisong</surname><given-names>A.</given-names></name>
<name><surname>Koonyosying</surname><given-names>P.</given-names></name>
<name><surname>Tangtrongsup</surname><given-names>S.</given-names></name>
<name><surname>Tiwananthagorn</surname><given-names>S.</given-names></name>
<name><surname>Sthitmatee</surname><given-names>N.</given-names></name>
</person-group><article-title>Effect of GP19 peptide hyperimmune antiserum on activated macrophage during <italic toggle="yes">Ehrlichia canis</italic> infection in canine macrophage-like cells</article-title><source>Animals</source><year>2021</year><volume>11</volume><elocation-id>2310</elocation-id><pub-id pub-id-type="doi">10.3390/ani11082310</pub-id><pub-id pub-id-type="pmid">34438767</pub-id>
</element-citation></ref><ref id="B86-vetsci-11-00624"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nambooppha</surname><given-names>B.</given-names></name>
<name><surname>Rittipornlertrak</surname><given-names>A.</given-names></name>
<name><surname>Muenthaisong</surname><given-names>A.</given-names></name>
<name><surname>Koonyosying</surname><given-names>P.</given-names></name>
<name><surname>Chomjit</surname><given-names>P.</given-names></name>
<name><surname>Sangkakam</surname><given-names>K.</given-names></name>
<name><surname>Sthitmatee</surname><given-names>N.</given-names></name>
</person-group><article-title>Recombinant <italic toggle="yes">Ehrlichia canis</italic> GP19 protein as a promising vaccine prototype providing a protective immune response in a mouse model</article-title><source>Vet. Sci.</source><year>2022</year><volume>9</volume><elocation-id>386</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci9080386</pub-id><pub-id pub-id-type="pmid">36006302</pub-id>
</element-citation></ref><ref id="B87-vetsci-11-00624"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Godzik</surname><given-names>A.</given-names></name>
</person-group><article-title>Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences</article-title><source>Bioinformatics</source><year>2006</year><volume>22</volume><fpage>1658</fpage><lpage>1659</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btl158</pub-id><pub-id pub-id-type="pmid">16731699</pub-id>
</element-citation></ref><ref id="B88-vetsci-11-00624"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shawan</surname><given-names>M.M.A.K.</given-names></name>
<name><surname>Sharma</surname><given-names>A.R.</given-names></name>
<name><surname>Halder</surname><given-names>S.K.</given-names></name>
<name><surname>Arian</surname><given-names>T.A.</given-names></name>
<name><surname>Shuvo</surname><given-names>M.N.</given-names></name>
<name><surname>Sarker</surname><given-names>S.R.</given-names></name>
<name><surname>Hasan</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Advances in computational and bioinformatics tools and databases for designing and developing a multi-epitope-based peptide vaccine</article-title><source>Int. J. Pept. Res. Ther.</source><year>2023</year><volume>29</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.1007/s10989-023-10535-0</pub-id><pub-id pub-id-type="pmid">37251529</pub-id>
</element-citation></ref><ref id="B89-vetsci-11-00624"><label>89.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Reche</surname><given-names>P.A.</given-names></name>
</person-group><source>Computational Vaccine Design</source><edition>1st ed.</edition><publisher-name>Humana</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2023</year><fpage>535</fpage><pub-id pub-id-type="doi">10.1007/978-1-0716-3239-0?nosfx=y</pub-id></element-citation></ref><ref id="B90-vetsci-11-00624"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adams</surname><given-names>L.</given-names></name>
<name><surname>Obiri-Yeboah</surname><given-names>D.</given-names></name>
<name><surname>Afiadenyo</surname><given-names>M.</given-names></name>
<name><surname>Hamidu</surname><given-names>S.</given-names></name>
<name><surname>Aning</surname><given-names>A.</given-names></name>
<name><surname>Ehun</surname><given-names>E.</given-names></name>
<name><surname>Shiels</surname><given-names>K.</given-names></name>
<name><surname>Joshi</surname><given-names>A.</given-names></name>
<name><surname>Mamfe Sakyimah</surname><given-names>M.</given-names></name>
<name><surname>Asamoah Kusi</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>An <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in silico</italic> investigation of the antitrypanosomal activities of the stem bark extracts of <italic toggle="yes">Anopyxis klaineana</italic> (Pierre) Engl</article-title><source>Heliyon</source><year>2024</year><volume>10</volume><fpage>e28025</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e28025</pub-id><pub-id pub-id-type="pmid">38545221</pub-id>
</element-citation></ref><ref id="B91-vetsci-11-00624"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>N.</given-names></name>
<name><surname>Bevan</surname><given-names>M.J.</given-names></name>
</person-group><article-title>CD8+ T cells: Foot soldiers of the immune system</article-title><source>Immunity</source><year>2011</year><volume>35</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.07.010</pub-id><pub-id pub-id-type="pmid">21867926</pub-id>
</element-citation></ref><ref id="B92-vetsci-11-00624"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Embgenbroich</surname><given-names>M.</given-names></name>
<name><surname>Burgdorf</surname><given-names>S.</given-names></name>
</person-group><article-title>Current concepts of antigen crosspresentation</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><elocation-id>1643</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.01643</pub-id><pub-id pub-id-type="pmid">30061897</pub-id>
</element-citation></ref><ref id="B93-vetsci-11-00624"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Budachetri</surname><given-names>K.</given-names></name>
<name><surname>Teymournejad</surname><given-names>O.</given-names></name>
<name><surname>Lin</surname><given-names>M.</given-names></name>
<name><surname>Yan</surname><given-names>Q.</given-names></name>
<name><surname>Mestres-Villanueva</surname><given-names>M.</given-names></name>
<name><surname>Brock</surname><given-names>G.N.</given-names></name>
<name><surname>Rikihisa</surname><given-names>Y.</given-names></name>
</person-group><article-title>An entry-triggering protein of <italic toggle="yes">Ehrlichia</italic> is a new vaccine candidate against tick-borne human monocytic ehrlichiosis</article-title><source>MBio</source><year>2020</year><volume>11</volume><fpage>10</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1128/mBio.00895-20</pub-id></element-citation></ref><ref id="B94-vetsci-11-00624"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Budachetri</surname><given-names>K.</given-names></name>
<name><surname>Lin</surname><given-names>M.</given-names></name>
<name><surname>Chien</surname><given-names>R.C.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Brock</surname><given-names>G.N.</given-names></name>
<name><surname>Rikihisa</surname><given-names>Y.</given-names></name>
</person-group><article-title>Efficacy and immune correlates of OMP-1B and virB2-4 vaccines for protection of dogs from tick transmission of <italic toggle="yes">Ehrlichia chaffeensis</italic></article-title><source>MBio</source><year>2022</year><volume>13</volume><fpage>e02140-22</fpage><pub-id pub-id-type="doi">10.1128/mbio.02140-22</pub-id><pub-id pub-id-type="pmid">36342170</pub-id>
</element-citation></ref><ref id="B95-vetsci-11-00624"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kowalzik</surname><given-names>F.</given-names></name>
<name><surname>Schreiner</surname><given-names>D.</given-names></name>
<name><surname>Jensen</surname><given-names>C.</given-names></name>
<name><surname>Teschner</surname><given-names>D.</given-names></name>
<name><surname>Gehring</surname><given-names>S.</given-names></name>
<name><surname>Zepp</surname><given-names>F.</given-names></name>
</person-group><article-title>mRNA-based vaccines</article-title><source>Vaccines</source><year>2021</year><volume>9</volume><elocation-id>390</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines9040390</pub-id><pub-id pub-id-type="pmid">33921028</pub-id>
</element-citation></ref><ref id="B96-vetsci-11-00624"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Latif</surname><given-names>A.A.</given-names></name>
<name><surname>Steyn</surname><given-names>H.C.</given-names></name>
<name><surname>Josemans</surname><given-names>A.I.</given-names></name>
<name><surname>Marumo</surname><given-names>R.D.</given-names></name>
<name><surname>Pretorius</surname><given-names>A.</given-names></name>
<name><surname>Troskie</surname><given-names>P.C.</given-names></name>
<name><surname>Mans</surname><given-names>B.J.</given-names></name>
</person-group><article-title>Safety and efficacy of an attenuated heartwater (<italic toggle="yes">Ehrlichia ruminantium</italic>) vaccine administered by the intramuscular route in cattle, sheep and Angora goats</article-title><source>Vaccine</source><year>2020</year><volume>38</volume><fpage>7780</fpage><lpage>7788</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2020.10.032</pub-id><pub-id pub-id-type="pmid">33109388</pub-id>
</element-citation></ref><ref id="B97-vetsci-11-00624"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gordon</surname><given-names>J.L.</given-names></name>
<name><surname>Oliva Chavez</surname><given-names>A.S.</given-names></name>
<name><surname>Martinez</surname><given-names>D.</given-names></name>
<name><surname>Vachiery</surname><given-names>N.</given-names></name>
<name><surname>Meyer</surname><given-names>D.F.</given-names></name>
</person-group><article-title>Possible biased virulence attenuation in the Senegal strain of <italic toggle="yes">Ehrlichia ruminantium</italic> by ntrX gene conversion from an inverted segmental duplication</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><elocation-id>e0266234</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0266234</pub-id><pub-id pub-id-type="pmid">36800354</pub-id>
</element-citation></ref><ref id="B98-vetsci-11-00624"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Madesh</surname><given-names>S.</given-names></name>
<name><surname>McGill</surname><given-names>J.</given-names></name>
<name><surname>Jaworski</surname><given-names>D.C.</given-names></name>
<name><surname>Ferm</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Fitzwater</surname><given-names>S.</given-names></name>
<name><surname>Ganta</surname><given-names>R.R.</given-names></name>
</person-group><article-title>Long-Term Protective Immunity against <italic toggle="yes">Ehrlichia chaffeensis</italic> Infection Induced by a Genetically Modified Live Vaccine</article-title><source>Vaccines</source><year>2024</year><volume>12</volume><elocation-id>903</elocation-id><pub-id pub-id-type="doi">10.3390/vaccines12080903</pub-id><pub-id pub-id-type="pmid">39204029</pub-id>
</element-citation></ref><ref id="B99-vetsci-11-00624"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tshilwane</surname><given-names>S.I.</given-names></name>
<name><surname>Thema</surname><given-names>N.</given-names></name>
<name><surname>Steyn</surname><given-names>H.C.</given-names></name>
<name><surname>Van Kleef</surname><given-names>M.</given-names></name>
<name><surname>Pretorius</surname><given-names>A.</given-names></name>
</person-group><article-title>A multi-epitope DNA vaccine co-administered with monophosphoryl lipid A adjuvant provides protection against tick transmitted <italic toggle="yes">Ehrlichia ruminantium</italic> in sheep</article-title><source>Vaccine</source><year>2019</year><volume>37</volume><fpage>4354</fpage><lpage>4363</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2019.06.027</pub-id><pub-id pub-id-type="pmid">31248684</pub-id>
</element-citation></ref><ref id="B100-vetsci-11-00624"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pretorius</surname><given-names>A.</given-names></name>
<name><surname>Nefefe</surname><given-names>T.</given-names></name>
<name><surname>Thema</surname><given-names>N.</given-names></name>
<name><surname>Liebenberg</surname><given-names>J.</given-names></name>
<name><surname>Steyn</surname><given-names>H.</given-names></name>
<name><surname>van Kleef</surname><given-names>M.</given-names></name>
</person-group><article-title>Screening for immune biomarkers associated with infection or protection against <italic toggle="yes">Ehrlichia ruminantium</italic> by RNA-sequencing analysis</article-title><source>Microb. Pathog.</source><year>2024</year><volume>189</volume><fpage>106588</fpage><pub-id pub-id-type="doi">10.1016/j.micpath.2024.106588</pub-id><pub-id pub-id-type="pmid">38369169</pub-id>
</element-citation></ref><ref id="B101-vetsci-11-00624"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dias</surname><given-names>F.</given-names></name>
<name><surname>Couto</surname><given-names>J.</given-names></name>
<name><surname>Ferrolho</surname><given-names>J.</given-names></name>
<name><surname>Seron</surname><given-names>G.S.</given-names></name>
<name><surname>Bell-Sakyi</surname><given-names>L.</given-names></name>
<name><surname>Antunes</surname><given-names>S.</given-names></name>
<name><surname>Domingos</surname><given-names>A.</given-names></name>
</person-group><article-title>Folate pathway modulation in <italic toggle="yes">Rhipicephalus</italic> ticks in response to infection</article-title><source>Transbound. Emerg. Dis.</source><year>2020</year><volume>67</volume><issue>(Suppl. S2)</issue><fpage>94</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1111/tbed.13231</pub-id><pub-id pub-id-type="pmid">31231926</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-11-00624-f001"><label>Figure 1</label><caption><p>Geographical distribution of <italic toggle="yes">Ehrlichia canis</italic> genogroups based on the Tandem Repeat Proteins 36 (TRP36) genes reported in the literature until 2024 as genotypes: American (USTRP36), Brazilian (BrTRP36), Costa Rican (CRTRP36), Taiwanese, and Cuban (CUBTRP36).</p></caption><graphic xlink:href="vetsci-11-00624-g001" position="float"/></fig><fig position="float" id="vetsci-11-00624-f002"><label>Figure 2</label><caption><p>The immune response is stimulated by a vaccine antigen using a subunit vaccine with multiple epitopes (linear and/or conformational) of <italic toggle="yes">Ehrlichia canis</italic>. The presentation of cross-antigens to antigen-presenting cells (APC) is expressed by the major histocompatibility complex (MHC) type II and I processes. The molecules expressed by MHC-II activate Th1 cell receptors that stimulate the immune response of CD4+ T cells and, consequently, secretion of interferon-&#x003b3; (IFN-&#x003b3;) and interleukin-2 (IL-2). In contrast, activated Th2 cell receptors induce the development of B cells that differentiate into memory cells and antibody-secreting plasma cells. The molecules expressed by MHC-I induce the response of CD8+ T cells, triggering a cytotoxic response to antigens through the production of tumor necrosis factor-&#x003b1; (TNF-&#x003b1;).</p></caption><graphic xlink:href="vetsci-11-00624-g002" position="float"/></fig></floats-group></article>